Patient-specific femoroacetabular impingement instruments and methods

Abstract
A device for a patient-specific acetabular and/or femoral guide. The guides can be used in a selected resection of at least one of a femur and an acetabulum to increase a range of motion of the femur relative to the acetabulum. Generally, a natural acetabulum and femoral head are maintained.
Description
INTRODUCTION

The present teachings provide patient-specific devices, which can include at least guides and implants, and methods for preparing one or both of a femur and an acetabulum for a selected range of motion, and particularly to increasing a range of motion of a natural femur within an acetabulum.


SUMMARY

This section provides a general summary of the disclosure, and is not a comprehensive disclosure of its full scope or all of its features.


A system is disclosed that can be used to design instruments for and perform a procedure on a specific patient. A patient-specific device can be a device that substantially matches a patient's anatomy, as discussed further herein, to perform a selected procedure on the patient. The patient-specific device is operable to conform to the anatomy of a single patient for performing the selected procedure. In other words, as discussed further herein, the patient specific device includes at least a surface that is designed to specifically engage the anatomy of a single patient in substantially a single position and orientation based on obtained information about a geometry of the single patient. This can include the contacting surface formed as a negative of a modeled positive geometry of the single patient


The devices can include those that are operable to guide a mill or reamer instrument to remove a defect or abnormality from a selected portion of the anatomy. For example, a femur's articulation with an acetabulum (also referred to as femoroacetabular impingement). In femoroacetabular impingement, a femur, or a portion thereof, can have a bone abnormality that impinges on a portion of the acetabulum defined by the pelvis to limit a range of motion of the femur relative to the pelvis. Accordingly, a patient-specific device can be designed to assist in guiding or removal of a portion of at least one of the acetabulum or the femur of the patient to assist in increasing a range of motion of the femur relative to the pelvis.


Further areas of applicability will become apparent from the description provided herein. The description and specific examples in this summary are intended for purposes of illustration only and are not intended to limit the scope of the present disclosure.





DRAWINGS

The drawings described herein are for illustrative purposes only of selected embodiments and not all possible implementations, and are not intended to limit the scope of the present disclosure.



FIG. 1 is a detail environmental view of a patient with an identified femoral articulation range limitation;



FIG. 2 is a flowchart illustrating a method of preparing a selected patient-specific guide system, according to various embodiments;



FIG. 3A is a surgeon input screen, according to various embodiments;



FIG. 3B is a view of a display device illustrating image data of a patient with a region to be removed;



FIG. 4A is a perspective exploded view of a reamer guide, according to various embodiments;



FIG. 4B is an interior perspective view of the reamer guide;



FIG. 5 is an environmental view of the reamer guide;



FIG. 5A′ is an environmental view of a lateral femoral neck reamer guide;



FIG. 5B′ is a bone contacting surface plan view of the lateral femoral neck reamer guide;



FIG. 6 is an environmental view of a template relative to a bone;



FIG. 7 is an environmental view of a template contacting a bone portion;



FIG. 8 is an environmental view of a second contact of the template to the bone portion after further resection as compared to FIG. 7;



FIG. 9 is a perspective view of a greater trochanter resection guide, according to various embodiments;



FIG. 10 is a second perspective view of the greater trochanter resection guide;



FIG. 11 is a bottom plan view of an acetabular resection guide, according to various embodiments;



FIG. 12 is a top environmental perspective view of the acetabular reamer; and



FIG. 13 is a top view of a kit of instruments and/or implants, according to various embodiments.





Corresponding reference numerals indicate corresponding parts throughout the several views of the drawings.


DETAILED DESCRIPTION

Exemplary embodiments will now be described more fully with reference to the accompanying drawings.


The present teachings generally provide a patient-specific (custom) guide and method for a selected arthroplasty of a patient, including partial acetabular socket resection, partial femoral resection and/or replacement or other similar procedure. More specifically, the present teachings provide a patient-specific guide for the acetabulum of the patient, when the acetabulum includes a defect that can be corrected by a partial socket resection or a partial implant. The present teachings also provide a patient-specific guide for the femur, including the femoral head and/or femoral neck of the patient, when the femoral head and/or neck includes a defect that can be corrected by a partial resection or a partial implant. Generally, patient-specific guides are those guides that are designed and manufactured based upon the specific anatomy geometry and configuration of a single selected patient. The specific geometry and configuration of the anatomy of the single patient is generally determined as discussed below (e.g. via modeling) and also generally based upon specific instructions from an intended user and/or implanter of the patient-specific devices.


Generally, patient-specific devices can be designed preoperatively using computer-assisted image methods based on three- or two-dimensional image data of the patient's anatomy reconstructed from magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, or other three- or two-dimensional medical scans of the patient's anatomy. In some cases patient-specific device design can be complemented with digital photography methods and/or anthropometry databases. Various CAD programs and/or software can be utilized for three-dimensional image reconstruction, such as, for example, software commercially available by Materialise USA, Plymouth, Mich.


Various alignment guides and pre-operative planning procedures are disclosed in commonly assigned and co-pending U.S. patent application Ser. No. 11/756,057, filed on May 31, 2007, U.S. patent application Ser. No. 12/211,407, filed Sep. 16, 2008; U.S. patent application Ser. No. 11/971,390, filed on Jan. 9, 2008, U.S. patent application Ser. No. 11/363,548, filed on Feb. 27, 2006; U.S. patent application Ser. No. 12/025,414, filed Feb. 4, 2008, U.S. patent application Ser. No. 12/571,969, filed Oct. 1, 2009, and U.S. patent application Ser. No. 12/955,361, filed Nov. 29, 2010. The disclosures of the above applications are incorporated herein by reference.


In the preoperative planning stage for a femoroacetabular resection procedure, imaging data of the relevant anatomy of a single specific patient can be obtained at a medical facility or doctor's office, using one of medical imaging methods described above. The imaging data can include, for example, various medical scans of a relevant joint portion or other relevant portion of the single specific patient's anatomy, as needed for modeling, including three-dimensional (3D) modeling, further including 3D joint modeling. The image data can also be used, optionally, for implant alignment axis determination or for other alignment purposes. The imaging data thus obtained and other associated information can be used to construct a three-dimensional computer image of the joint or other portion of the anatomy of the single specific patient.


According to the present teachings, the patient-specific guides and implants are generally configured to match the anatomy of the single specific patient and are generally formed using computer modeling based on the single specific patient's reconstructed three-dimensional anatomic image. The patient-specific guides have an engagement surface that is made to conformingly contact and match a three-dimensional image/model of a bone surface of the single specific patient's (with or without cartilage or other soft tissue), by the computer methods discussed above. That is, a bone surface contacting surface of the patient-specific guide is intended to be a negative or similar to a mirror image of the bone surface of the single specific patient for which the patient-specific device is designed and manufactured. In this respect, a patient-specific guide can nestingly mate with the corresponding bone surface (with or without articular cartilage) of the single specific patient in only one position.


According to the present teachings, the patient-specific guide can include a custom-made (patient-specific) guiding formation, such as, for example, a mill guide for guiding a joint preparation tool, such as a reamer, cutter, broach, mill, drill or other cutting tool, according to the pre-operative plan for the patient. In some embodiments, the guiding formation can have a patient-specific size and shape configured during preoperative planning for the single specific patient to guide a milling tool, a reamer, a saw or other cutting tool, as discussed below. The preoperative plan can include planning for bone or joint preparation, including extent and area for defect removal, by milling, reaming, broaching or other cutting method, as well as implant selection and fitting. Also, a final or ideal range of motion can be selected.


The patient-specific guide described herein can be manufactured by various stereolithography methods, selective laser sintering, fused deposition modeling or other rapid prototyping methods. The patient-specific guide can be made of any biocompatible material, including metal, metal alloys or plastic. Generally, the patient-specific guide is made of lightweight materials, including polymers. The patient-specific implant can, however, also include or be formed entirely of any biocompatible materials, including metals and alloys. The patient-specific guide, implant and associated tools can be sterilized and shipped to the surgeon or medical facility in a kit for a specific patient and surgeon for use during the surgical procedure. The patient-specific guides may then be disposed after the procedure for which the patient-specific devices were designed and planned. Thus, the patient-specific devices as disclosed herein can be disposable or single procedure devices.


With reference to FIG. 1, an anatomy of a single specific patient (SSP) can include a pelvis 20 that defines an acetabulum 22. A femur 24 can articulate within the acetabulum 22. Generally the femur 24 can include a femoral head 26 that defines an articular surface that articulates with the acetabulum 22. A greater trochanter 26 extends from the femur 24 and generally allows for soft tissue attachment to the femur 24. Extending between the greater trochanter 28 and the head 26 is a femoral neck 30. The neck 30 allows the head 26 to be positioned within the acetabulum 22 while the greater trochanter 28 and the body of the femur 24 is positioned away from the pelvis 20 to allow for a range of movement of the femur 24 relative to the pelvis 20. The femoral neck 30, however, may include a defect or bone abnormality 32. The bone abnormality 32 can be congenital or develop over time due to disease or injury. Regardless, the defect or abnormality 32 can impinge upon the acetabulum, such as near a rim or edge (e.g. a high portion 400 in FIG. 9) of the acetabulum 22, to limit a range of motion of the femur 24 relative to the pelvis 20. The range of motion of the femur 24 relative to the pelvis 20 can be one that substantially limits motion of the femur 24 relative to the pelvis 20 or one that causes discomfort in a range of motion of the femur 24 relative to the pelvis 20.


Regardless, the bone abnormality 32 can be selected to be removed. In a procedure, a surgeon can obtain access to the patient's anatomy, such as through an incision, and through the surgeon's skill and experience, selectively remove a portion of the bone abnormality 32. Exemplary procedures are disclosed in Beaule, Paule et al., The Young Adult With Hip Impingement: Deciding on The Optimal Intervention, The Journal of Bone and Joint Surgery, Volume 91-A, #1, page 210-221, January 2009, incorporated herein by reference. As disclosed herein a femoral articular impingement can be cured or relieved by removing a portion of the bone defect 32 as planned by a surgeon and with a patient-specific device regarding a single specific patient (SSP). The patient specific device can assist in removing a selected portion of the anatomy to achieve a selected or proposed result on the SSP. As described further herein, as illustrated in FIG. 2, a procedure 50 can be followed to obtain specific information of the SSP, plan a procedure, design patient-specific devices for achieving the procedure, and selecting an appropriate result. Accordingly, the procedure 50 illustrated in FIG. 2 can be used to generate patient-specific devices to achieve a patient-specific result as selected by a user.


Referring to FIG. 2, in preoperative planning, imaging data can be obtained of a selected portion of the SSP including an entire leg, further including a joint to be reconstructed at a medical facility or doctor's office, at block 60. The imaging data can include a detailed scan of a hip, knee and ankle. The imaging data can be obtained using MRI, CT, X-Ray, ultrasound or any other imaging system. In some cases, the scan may be performed with the SSP wearing an unloader brace to stress the ligaments. The scan data obtained can be sent to a manufacturer, at block 64. The scan data can be used by the manufacturer to construct a three-dimensional (3D) image of the selected joint. The 3D image or 3D image data can be used to generate a 3D model that can be used to design and manufacture patient specific devices, as discussed herein. Generally, and depending on the procedure, an initial fitting, guiding, and alignment protocol detailing the fit of any implant components and/or various alignment, milling, reaming and cutting instruments can be prepared. The fitting and alignment protocol can be stored in any computer storage medium (including a local or networked hard disk drive or other stable or temporary storage medium), in a computer file form or any other computer or digital representation. The initial fitting and alignment protocol can be obtained using standard alignment methods or using alignment methods provided by or based on the preferences of individual surgeons.


As discussed above, in the preoperative planning stage of a surgical procedure, multiple image scans of portions of the SSP's anatomy related to the procedure are obtained. Image markers visible in the scan can be placed on the SSP's anatomy to allow image scaling and orientation. The obtained scans of the desired anatomy can be correlated to one another to reconstruct an image of the patient's specific anatomy in three-dimensions.


The outcome of the initial fitting is an initial surgical plan created at block 68 that can be printed or represented in electronic form with corresponding viewing software. The initial surgical plan can be surgeon-specific, when using surgeon-specific alignment protocols. The initial surgical plan, in a computer file form associated with interactive software, can be sent to the surgeon, or other medical practitioner, for review, at 72 (and viewable as a computer display 80 in FIG. 3). Using the interactive software, the surgeon can manipulate the position of images of various implant components (when used) and/or alignment/milling/reaming guides or other instruments relative to an image of the joint. Other modifications can include range of movement selections or general sizes and interactions of anatomical portions of the SSP. The surgeon can modify the plan and send it to the manufacturer with recommendations or changes. The interactive review process can be repeated until a final, approved plan is sent to the manufacturer, at 110.


Once the imaging scan has been used to collect scan data, including imaging scan data, in block 60 and, as discussed above, the initial surgical plan is sent to the surgeon in block 72. The initial surgical plan can be viewed as illustrated in FIG. 3A. In FIG. 3A, a screen image 80 is illustrated. The screen image 80 can include selected information such as a surgeon's name, patient name, and other surgeon and patient-specific information. A portion of the screen 80 can include a first block or screen block 82 that describes a proposed femoral head diameter. A second screen block 84 can illustrate a proposed minimal femoral neck diameter. A third screen block 86 can describe a reamer or reamer size to be used.


The reamer to be used can include a radius size of the reaming portion or head of the reamer. The reamer size can be equal to a portion of the Head-to-Neck offset. The Head-to-Neck offset can be the difference between the diameter of the head and the diameter of the neck of the femur to be resected. The size of the reamer can be about one third to about two thirds, including about one half of the value of the difference. As an example, the diameter of the head may be 40 mm and the diameter of the neck may be 24 mm, therefore the difference is 16 mm. The reamer size can be about one half the difference, or about 8 mm as illustrated in block 86.


The computer screen 80 can also include a fourth screen block 88 that illustrates an a angle 90. The a angle 90 can be an angle between a line 90a from a center of the femoral head 26 down a center of the femoral neck 30 (e.g. the long axis of the femoral neck) to a line 90b. The line 90b can be defined between the center of the femoral head 26 and an intersection of a circle defined by the center of the femoral head 26 having a radius from the center to an edge of the spherical portion of the femoral head and where the circle intersects a non-spherical portion of the femoral head 26 by the femoral neck. The a angle 90 can be used to illustrate a range of motion of the SSP after the initially proposed plan in block 72 and illustrated on screen 80.


In a fifth screen block 94, a center edge angle 96 is illustrated. The center edge angle 96 is an angle between a first line 96a that extends from a center of the femoral head 26 to a superior rim of the acetabulum 22 and a second line 96b extending from the center of the femoral head 26 substantially parallel with the long axis of the femur 24 or a mechanical axis of the anatomy. The center edge angle 96 can also be used to assist in determining or designing various guide members, as discussed herein.


Finally, a sixth screen block 98 can illustrate a range of motion, from various perspectives, for viewing by the surgeon based upon a modification of the SSP with the initially proposed plan or procedure and the instruments designed therefrom. Accordingly, the screen 80 is a representation of the initial surgical plan sent to the surgeon in block 72. The initial surgical plan, as discussed above, is based upon the scan data sent to the manufacturer in block 64.


The six screen blocks 82-98 can be used to describe information received based upon the imaging scan data sent to the manufacturer in block 64 and information based upon the suggested or initially suggested sizes to achieve a selected range of motion within the SSP after the selected procedure. With continuing reference to FIGS. 2 and 3, the surgeon can finalize, including changing and altering the initial plan, and sending the plan to the manufacturer in block 110 of the procedure 50. The surgeon can alter the plan by changing the a angle 90 in screen block 88 and the center edge angle in screen block 94. The two angles can be altered by inputs from the surgeon directly into a computer file that is included or that generates the screen 80 or sent separately for consideration by the manufacturer. Additionally, the specific size or positioning of various portions of the instruments, such as discussed herein including a reamer guide, can be altered by the surgeon when finalizing the initial plan. The surgeon can then send the finalized plan to the manufacturer in block 110.


According to various embodiments the screen image 80 of a display device can also illustrate the image data of the patient with a planned removal region 32′ illustrated, for example, with shading or varying colors as shown in FIG. 3B. The planned removal region 32′ can relate to the defect 32 or any appropriate region to be removed based upon the finalized plan. It is also understood that the planned removal region 32′ may be shown to change based upon variations in the planning. The planned removal region 32′ can be used to design and manufacture any appropriate device, as discussed further herein.


Various methods of sending the initial and final surgeon-approved surgical plans can be used. The surgical plans can be, for example, transferred to an electronic storage medium, such as CD, DVD, flash memory, which can then be mailed using regular posting methods. In various embodiments, the surgical plan can be e-mailed in electronic form or transmitted through the internet or other web-based service.


Based upon the finalized plan in block 110, patient-specific devices are then designed in block 120. The patient specific devices can include patient-specific alignment/milling/reaming or other guides. The patient specific devices for the SSP's joint can be developed using a CAD program or other three-dimensional modeling software, such as the software provided by Materialise, for example, according to the surgical plan, at 120.


Patient-specific guides can then be manufactured and sterilized at 124. The guides can be manufactured by various stereolithography methods, selective laser sintering, fused deposition modeling or other rapid prototyping methods. In some embodiments, computer instructions of tool paths for machining the patient-specific guides can be generated and stored in a tool path data file. The tool path can be provided as input to a CNC mill or other automated machining system, and the alignment guides can be machined from polymer, ceramic, metal or other suitable material. Patient-specific devices are defined as those constructed by a surgical plan, such as the finalized pan, approved by the doctor using three-dimensional images (including 3D models based on the image data) of the SSP's anatomy and made to closely conform and mate substantially as a negative mold to corresponding portions of the patient's anatomy, including bone surfaces with or without associated soft tissue, such as articular cartilage, for example.


Images of the hip joint anatomy of the joint surface of the proximal femur with or without the associated soft tissues, such as articular cartilage, on the respective bone surfaces can be used in the alignment procedure. The alignment procedure can include, for example, the selection of an anteversion angle, a femoral neck angle and other orientations for positioning a femoral implant, such as a resurfacing component, without notching or impinging on the femoral neck. Multiple alignment procedures can be provided to accommodate the experience and preference of individual surgeons. For example, the alignment procedure can be based on the anatomic and mechanical axes. Further, the alignment procedure can be deformity-specific in relation, for example, to various deformities and/or malformations of the hip joint anatomy, articulation and orientation.


The sterilized devices can be shipped to the surgeon or medical facility, at 126 for use during the surgical procedure. The sterilized devices, therefore, can be included in a single kit 450 (FIG. 10) for delivery to a user, such as a surgeon, as a single unit. The sterilized devices also need not be kept in inventory at a place of use, but can be manufactured and shipped on demand for a particular procedure on the SSP. It is also understood, that the patient specific devices need not be sterilized prior to shipping, but that prior sterilization can decrease later processing at a facility of use of the patient specific devices.


One of the patient specific devices to achieve the finalized plan from block 110 (including alignment and/or range of motion) can include a femoral neck reamer guide 200, as illustrated in FIGS. 4A, 4B, and 5. The femoral reamer guide 200 can be one of a plurality or the only patient-specific device designed, manufactured, and shipped (blocks 120, 124, and 126) based upon the plan 50. Nevertheless, the portions of the neck reamer guide 200 are discussed herein.


Initially, the neck reamer guide 200 can also be referred to as a milling guide. Generally, the neck reamer guide 200 includes femur contacting portion. The femur contacting portion can include a reamer cap or dome portion 210 that includes a reamer interior or bone contacting surface 212 that substantially mates with an articular portion of the femoral head 26 based upon the scan data sent to the manufacturer in block 64 of the procedure 50. The interior surface 212 of the reamer guide 200 can include contours and geometries that substantially mirror or form a negative relative to the shape of the articular surface of the femoral head 26. Accordingly, the interior surface 212 can mate substantially tightly or nest substantially tightly and in substantially only one configuration with the femoral head 26 of the SSP. In other words, the reamer interior surface 212 can be designed and manufactured to engage the femoral head of substantially only the SSP in a manner appropriate for guiding a reamer, as discussed herein.


Various portions can extend from the dome portion 210. A neck extension finger 220 that extends along the neck 30 of the femur 24 and can also extend down a portion of the shaft of the femur 24, if selected, can extend from the dome 210. The extension finger 220 can assist in further conformational holding of the reamer guide 200 relative to the femur 24. Thus, the finger 220 can include an anatomy contacting surface that mirrors or is a negative of a selected portion of the femur 24.


To assist in holding the reamer guide 200 relative to the femur 24, pins or screws can engage the femur 24. For example, a first screw 230 can pass through a first passage 232 in the extension finger 220 and engage the femur 24. The screw 230 can extend at an angle that would pass towards the greater trochanter 28 of the femur 24. Additionally, a second screw 236 can pass through a second passage 238 of the done 210 and engage a fovea capitis of the femoral head 26. Generally, the fovea capitis can be engaged with a screw without substantially damaging the articular region of the femoral head 26 due to the tissue attachment of the ligament teres between the femur 24 and the pelvis 20 within the acetabulum 22.


Accordingly, at least two screws 230 and 236 can be used to further fix the reamer guide 200 to the femur 24 of the SSP. Nevertheless, the femoral reamer guide 200 will substantially mate with the femur 24 of the SSP in substantially only one configuration or position due to the patient-specific device nature of the reamer guide 200, which was designed and manufactured based upon the scan data sent to the manufacturer in block 64. Thus, the guide 200 that is designed to assist in performing or carrying out the finalized plan procedure sent to the manufacturer in block 110 can ensure the completion of the procedure based upon the finalized plan due to the patient-specific device nature of the guide 200 because the guide 200 will engage the femur 24 of the SSP in substantially one configuration to guide a mill or reamer instrument 250 in substantially a single manner or path, as discussed herein.


The reamer instrument 250 that is guided with the guide body 200 is positioned with an arm or member 260 that can include a first portion 262 that extends from a pin or post 264. The pin 264 can extend from the dome portion 210 of the reamer guide 200 in any appropriate position. The first arm portion 262 can extend from the pin 264 in any appropriate manner to allow for positioning of a second arm portion 266 relative to the defect or bone abnormality 32 of the femur 24 such that the reamer instrument 250 can be guided with the guide 200 relative to the defect 32, generally in the direction of arrows 251 and 261, as discussed herein. The second arm portion 266 can be moved relative to the first arm portion 262, such as via an articulation or pin connection 270. The first arm portion 262 can be formed to be substantially rigid as can the second arm portion 266.


The articulating connection 270, therefore, can allow the second arm portion 266 to include a guide engaging surface 272 to contact a guide surface 274. The guide surface 274 can be formed with the reamer guide 200 to allow the second arm portion 266 to glide or move along the guide surface 274 to allow positioning of the reamer instrument 250 relative to the bone defect 32 in a manner according to the finalized plan sent to the manufacture in block 110. The guide surface can further include at least a first stop surface 276. The second guide arm portion 266, therefore, can move along the guide surface 274 until it engages the first stop 276. The guide 200 can further include a second stop portion 278.


Accordingly, the reamer guide 200 can define an arc, shown as arrow 261 that defines a range of movement of the second arm portion 266 relative to the pin 264. Thus, the guide arm 260 can guide the reamer instrument 250 along the arc 261 to remove the bone defect 32 in a selected manner. The reamer can also move in the direction of arrow 251 generally axially within the arm 260. An angle, length, and other geometric features of the arc 261 and the length of position of the arrow 251 relative to the defect 32 and the other portions the femur 24 can be designed based upon the finalized plan sent to the manufacturer in block 110, which is initially based upon the scanned data sent to the manufacturer in block 64. Accordingly, the reaming configuration that is defined by the guide surface 274, the two stops 276 and 278, the position of the pin 264, the configuration of the first arm portion 262 relative to the pin 264 and the articulation connection 270 and the surface 272 of the second arm portion 266 all cooperate to ensure an appropriative configuration of movement of the reaming or milling instrument 250 relative to the femur 24. As discussed above, the guide 200 is positioned relative to the femur 24 in substantially a single configuration or position due to the patient-specific nature of the reamer guide 200. Thus, the reaming of the defect 32 of the femur 24 is also substantially patient-specific to the SSP to ensure a selected result based upon the scanning data.


The reamer instrument 250 can be powered by any appropriate instrument, such as a drill motor 290. The drill motor 290 can be powered or operated by a surgeon to power the milling instrument 250 during the milling or reaming procedure. The movement of the reamer instrument 250, however, relative to the guide 200, can be based upon a force provided by the surgeon by moving the guide arm 260 along the surface 274 and between the two stops 276 and 278.


According to various embodiments, a lateral femoral neck reamer guide 200′ can also be provided or be provided as an alternative to the femoral neck reamer guide 200. The lateral femoral neck reamer guide 200′, as exemplary illustrated in FIGS. 5A′ and 5B′ can include portions that are similar to the femoral neck reamer guide 200 and these portions can include the same reference numerals augmented by a prime. Generally, the lateral femoral neck reamer guide 200′ can include a guide portion 210′ that is able or formed to contact or be positioned near a lateral portion of the femur 24, such as near the greater trochanter (which is show resected in FIG. 5A′ as discussed further herein) and/or a shaft 24a of the femur 24.


The lateral femoral neck guide 200′ can also be the defect reamer guide, as discussed above and herein. The lateral guide 200′, however, can be affixed to a lateral surface of a portion of the femur 24. For example, the lateral guide 200′ can include a first extension portion 201′ that can extend along a portion of a shaft 24a of the femur 24. A guide or guiding portion 210′ can also be positioned relative to a lateral portion of the femur 24, and contact a portion of the shaft 24a or a portion of the greater trochanter 28 or resected greater trochanter, as illustrated in FIG. 5A′. Nevertheless, the lateral reamer guide 200′ can include portions similar to the reamer guide 200, as discussed above, and be designed to resect a portion of the femoral neck 30, including the defect 32.


The lateral guide 200′ can include also include a bone contacting surface 212′ that is an interior surface, as illustrated in FIG. 5B′. The bone contacting surface 212′ is formed to include contours that substantially match at least a portion of the femur 24, such as a lateral surface of the femur 24a and the greater trochanter 28. The bone contacting surface 212′ can extend along the shaft portion 201′ and in the trochanter contacting portion 210′. The contours can substantially match or form a negative or mirror image of the femur 24 to assist in positioning the lateral reamer guide 200′ relative to the femur 24 for resecting the femur 24, according to the final plan. Accordingly, the lateral guide 200′ can be positioned relative to the femur 24 to position a reamer for reaming the defect 32 according to a process similar for the guide 200, as discussed above.


The lateral reamer guide 200′ can further include holding portions or fixing portions. A first screw 230′ can pass through a first passage 232′ and a second screw 236′ to pass through a second passage 238′. The screws or other fixation portions can assist in fixing the lateral guide 200 relative to the femur 24 during guiding of the reamer 250 relative to the femur 24.


Additionally, extending from the dome or guiding portion 210′ can be a pin 264′ that can engage a portion of a guide arm 260′ to allow the guide arm 260′ to generally move in at least a portion of an arc 261′ defined by the guide 200′. Similar to the guide 200, discussed above, the guide 200′ can include a guide surface 274′ and a second guide arm portion 266′ can include a guide surface to engage the guide surface 274′ of the guide 200′. A first arm portion 262′ can extend an engage the second arm portion 266′ at a hinge or flexing portion that can include a connection pin 270′.


The second arm portion 266′ can also include a holding or guiding portion to hold the reamer 250 and also allow the reamer 250 to move axially generally in the direction of arrow 251′ relative to the second guide arm portion 266′ and the guide 200′. Accordingly, the guide 200′ including or in operating the guide arm 260 can move or guide the reamer 250 for reaming a selected portion of the femur 24, such as the defect 32. It will be understood that the reamer 250 can be powered with a drill motor 290, as discussed above.


Additionally, the position of the guide surface 274′ can be developed based upon the final plan as discussed above. The guide surface 274′ can also be stopped or limited by first and second stop portions 276′ and 278′. The stop portions 276′ and 278′ limit movement of the second guide arm 266′ along the guide surface 274′ so that the guide arm 260′ moves relative to the femur 24 based upon the design of the lateral guide 200′ to resect the defect 32 or selected portion of the femur 24 based upon the final plan.


Accordingly, it will be understood, that the reamer 250 can be guided relative to the femur 24 with a selected patient specific guide or defect guide that can be positioned relative to the femur 24 in an appropriate manner. For example, the guide 200 can be positioned over the femoral head to guide the guide arm 260 relative to the femur 24. In addition, or alternatively thereto, the lateral guide 200′ can be positioned in a lateral portion of the femur 24 to guide the reamer 250 relative to the femur 24. It will be further understood that based upon a selected resection, two resection guides may be selected to achieve a selected amount of resection femur 24. For example, if a plurality of cuts or a complex angle is required or selected to resect the femur 24 in a selected manner, a plurality of the guides can be positioned on the femur 24 in a plurality of positions to achieve the selected resection.


As an alternative to the reamer guides 200, 200′ discussed above, a patient specific bone removal template 299, as illustrated in FIGS. 6-8, can be designed and manufactured to instruct a surgeon on the bone to be removed from the femur 24. As discussed above, the femur 24 can include the defect 32 that can be modeled and/or determined in the image data as the region to be removed 32′. The region to be removed 32′ can be used to generate a 3D model and further used to instruct (e.g. via a CAD model for manufacturing) a milling or 3D manufacturing machine to manufacture the template 299 based on the determined region to be removed 32


The template 299 can include a handle portion 301 to allow for grasping by a user, such as a surgeon. The handle 301 can interconnect with a template region 302 that has been specifically designed to match a patient and to indicate tissue to be removed. As discussed above, the bone removal region 32′ can be based upon the defect 32 of the femur 24. According to various embodiments, the template region 302 of the template 299 can be an inverse of the bone removal region 32′ such that when the bone removal region 32′ has been removed from the femur 24 that the template region 302 will contact the remaining femur portion 24 to substantially mimic the region to be removed 32′. To assist in reference or determining an appropriate amount of removal, reference fingers or tangs 304a-304d, can also be provided to engage regions of the femur 24 that are not intended to be removed. For example, the tangs 304a and 304b can contact regions of the neck 30 or the head 26 while the fingers 304c and 304d can contact regions around the greater trochanter 28. The template region 302, therefore, can be positioned to contact the femur 24 during portions of the bone removal procedure to assist the surgeon in determining whether an appropriate amount of bone has been removed.


With continuing reference to FIG. 6 and additional reference to FIGS. 7 and 8, a reamer 306, can be powered by a drill motor 308 that is operated by the surgeon to remove the bone defect 32. The reamer 306 can be operated to remove the bone defect 32 in incremental portions, such as about 1 or 2 mm layers per pass, such that the template 299 can be contacted to a bone resection region 32a after each pass or at a selected time to ensure that the selected amount of bone has been removed. It is understood, however, according to various embodiments, that a surgeon can determine that additional or less bone can be removed intraoperatively and uses the template 299 as a guide. As illustrated in FIG. 7, after a selected period of time, the template 299 can be contacted near the bone resection region 32a.


As illustrated in FIG. 7, if the template 299, including the template region 302 does not rest appropriately, such as flushly, with the surrounding bone surface around the bone resection region 32a, then resection can continue with the reamer 306 by the surgeon. After an additional portion of resection, the template 299 can be placed adjacent the bone resection region 32a again, as illustrated in FIG. 8, to confirm that the template region 302 of the template 299 rests substantially adjacent and/or in contact with the surrounding bone. Again, the positioning tangs 304a-d can be used to assist in confirming positioning of the template 299 relative to the adjacent portions of bone to ensure that the template region 302 is in the selected and appropriate position.


The template region 302 is based upon the determination of the region to be removed 32′ determined in the plan 50, discussed above. Accordingly, the device designed in block 120 can be the template 299 that is based upon the final surgeon plan in block 110. The template region 302 can be based upon the determination of the volume and position of bone that needs to be removed or is determined to be removed to achieve the selected movement of the femur 24. Accordingly, the template 299 can contact the bone at the bone resection region 32a to assist in confirming and determining an appropriate amount of bone to be removed.


It is understood that an opening or incision in the patient can allow for access to the femur 24 with the template 299 and that the same or different opening can be used to allow access of the reamer 306 to the femur 24 for resection. Accordingly, the bone can be resected at an appropriate rate and time until the template region 302 of the template 299 contacts the bone appropriately, such as flushily or with a determined clearance or contact amount. It is also understood that the template 299 can be used in conjunction with either of the guides 200 or 200′ discussed above to ensure an appropriate amount of the bone has been removed. Accordingly, once the selected guide 200 or 200′ has been used to resect an appropriate or selected portion of the bone, the template 299 can be used to confirm or fine tune any selected resection.


A second type of a patient specific device can include a greater trochanter guide 370 as illustrated in FIGS. 9 and 10. Accordingly, the trochanter guide 370 is a patient-specific device. The trochanter guide 370 can be designed and manufacturer based upon the scanned data sent to the manufacture in block 64 and the finalized plan sent to the manufacturer in block 110. The trochanter guide 370, therefore, can substantially mate with and contact a specific anatomy, including the greater trochanter 28 of the femur 24 of the SSP. Illustrated in FIGS. 9 and 10 is the femur 24 with no soft tissue surrounding the femur 24. It is understood by one skilled in the art, however, that soft tissue can be connected to the greater trochanter 28 as illustrated in FIG. 1. To allow for positioning of the reamer guide 200 on the femoral head 26, the greater trochanter 28 can be resected from the remaining portions of the femur 24 prior to dislocating the femur 24 from the acetabulum 22. The soft tissue connected to the greater trochanter 28, therefore, need not be stretched or moved substantially relative to the pelvis 20 and the acetabulum 22 when dislocating the femur 24 from the acetabulum 22 to perform the resection on the femur 24 and a resection to the acetabulum 22, as discuss further herein. Additionally, the greater trochanter guide 370 can be used to guide fixation pins or screw holes into the greater trochanter 28 relative to the femur 24 for reattachment of the greater trochanter 28 to the femur 24 after resecting the bone defect 32.


The trochanter guide 370 can include any appropriate size or area to contact the femur 24. Generally, the trochanter 370 can include a bone contacting surface 372 to contact the femur 24 in a substantially patient-specific manner. The contact surface 372 of the trochanter 370 can include a geometry that is substantially a mirror image or a negative of a portion of the femur 24. Accordingly, the trochanter guide 370 that is a patient-specific device can contact the SSP in substantially a single configuration or position to allow for resecting the greater trochanter 28 in a single selected manner. Generally, the mating and nesting of the greater trochanter 370 relative to the femur 24 is enough to maintain positioning of the trochanter 370 relative to the femur 24 for the resection and drilling procedures.


Once the access is made to the femur 24, the greater trochanter guide 370 can be positioned on the femur 24, as exemplarily illustrated in FIGS. 9 and 10. A plurality of bores, as exemplarily illustrated as three bores, can be drilled through three drill guide passages 374, 376 and 378 in a drill guide section 380 of the trochanter guide 370. The drill guide 380380 can allow for the drilling of passages 382, 384, and 386 through the greater trochanter 28 and through the remaining portion of the femur 24. Generally, the passages 382, 384, and 386 can be substantially through the femur 24 to allow for a purchase of a screw or a bolt into cortical bone that is substantially opposite the beginning or entry of the passages into the greater trochanter 28. The passages 382-386 can generally extend from the greater trochanter 28 to within the region 388 of the femur 24 generally near, such as slightly superior, the lesser trochanter 390.


After resection of the greater trochanter and resection of the bone defect 32, the greater trochanter 28 can then be reattached to the femur 24 with appropriately length screws or bolts. The passages 382-386 can be used to substantially precisely reattached the greater trochanter 28 to the femur 24. The lengths of the screws can also be determined prior to the procedure based upon the scan data sent to the manufacture in block 64. In determining the length of the screw prior to the procedure only an appropriate length screw can be provided as a portion of the patient-specific kit. Also, intra-operative measuring may not be necessary to ensure appropriate fixation of the screws through the greater trochanter 28 and into cortical bone substantially opposite the greater trochanter 28. Also, the number of screws may be limited in the kit as only one length can be provided, thus reducing cost per kit or cleaning of unused screws after a sterile seal is broken.


Once the screw passages 382-386 are drilled into the femur 24, a resection of the greater trochanter 28 can be performed at a substantially preplanned and precise position by using a cut guide slot 392 formed into the greater trochanter guide 370. The trochanter cut guide slot 392 can be positioned relative to the femur 24 based upon the patient-specific nature of the greater trochanter guide 370 to ensure an appropriate resection of the greater trochanter 28. An appropriate resection can include substantially no resection or limited disruption of any soft tissue connected to the greater trochanter 28, while ensuring an appropriate amount of bone in the resection to allow for an appropriate reattachment of the greater trochanter 28 to the femur 24. An appropriate instrument can be used to perform the resection such as a saw blade, including a reciprocating saw generally understood by one skilled in the art. An appropriate saw can include a reciprocating saw blade generally used for bone resection as generally understood by one skilled in the art. Once the resection of the greater trochanter 28 is completed, the trochanter guide 370 can be removed from the femur 24. Additionally, once the greater trochanter 28 is resected, the femur 24 can be dislocated from the acetabulum 22. Once the femur 24 is dislocated from the acetabulum 22, the defect milling guide 200 and/or 200′ can be connected to the femur 24 and/or femoral head 26 to allow for a resection or removal of the selected bone defect 32.


With reference to FIGS. 11 and 12, the acetabulum 22 can also be a portion of the diagnosis of the femoral acetabulum impingement on the femur, such as on the defect 32, can be determined. For example, a rim or upper portion or exterior portion of the acetabulum 22 can include portions that are substantially high relative to an internal portion of the acetabulum. A high rim portion 400 can extend beyond a low rim portion 402, relative to each other, and relative to a deep or internal portion of the acetabulum 22. The high rim portion 400 can be a distance 401 higher than an upper rim portion 420 of the acetabulum guide 410. Accordingly, an acetabulum cut guide 410 can be patient specific device as designed and manufactured to be seated or positioned within the acetabulum 22.


The acetabulum cut guide 410 can include the upper rim portion 420 that is connected to a central deep or low portion 422 with spokes or extension arms 424. It is understood that the acetabulum cut guide 410 can also be substantially solid rather than including a plurality of connection spokes 424, but the connection spokes that define the open areas 426 can assist in minimizing material, weight, and impingement on articulation portions of the acetabulum 22.


The acetabulum cut guide 410 can include a bone contacting surface defined at least by an exterior surface 430 of the extending spokes, an exterior surface 432 the rim 420, and an exterior surface 430 of the central portion 422. The bone contacting surfaces 430, 432, and 434 allow the acetabulum cut guide 410 to be positioned within the acetabulum 22 of the SSP in a substantially single configuration and position. Again, the geometry or configuration of the acetabulum 22 can allow for the design and manufacturer of the cut guide 410 in a substantially single configuration to engage the acetabulum 22 in a substantially single manner. Thus, the acetabulum cut guide 410 can be formed in a patient-specific manner to engage the acetabulum 22 of the SSP in a substantially single configuration.


Once the patient-specific acetabulum cut guide 410 is positioned within the acetabulum 22 of the SSP, an instrument can be used to engage an upper or cut guide surface or guide surface 440 of the rim 420. As the cutting or reaming instrument engages the upper surface 440 of the rim 420, the high regions 400 from around the acetabulum 22 can be removed. Thus, the upper edge or rim of the acetabulum 22 can be substantially minimized to achieve an appropriate range of motion of the femur 24 relative to the pelvis 20.


Accordingly, the reamer guide 200 and the acetabulum cut guide 410 can be formed in a substantially patient-specific manner including various configurations and materials as discussed above. The defect reamer guide 200 and the acetabulum cut guide 410 can be used individually or together to achieve the planned range of motion in the SSP. It will be understood that in selected patients, only the bone defect 32 reduces or minimizes the range of motion of the femur 24 relative to the pelvis 20. Accordingly, in various patients the finalized plan sent to the manufacture in block 110 need not include information that requires resection of a portion of the acetabulum 22. For example, if the Center Edge angle 96 is determined to be within an appropriate range, such as greater than about 40 degrees, an acetabular reamer guide 410 may not be necessary and therefore, not designed or provided. Nevertheless, the finalized plan sent to the manufacturer in block 110 can include information for forming or designing the defect reamer guide 200 and the acetabulum resection guide 410 to achieve a selected range of motion of the femur 24 relative to the pelvis 20. Additionally, the greater trochanter guide 370 can be designed in the patient-specific manner as discussed above, to allow resection of the greater trochanter to minimize or reduce any stretching of soft tissue connected to the trochanter during dislocation of the femur 24 to position the mill guide 200 relative to the femoral head 26.


As discussed above, all of the guides, including the reamer guide 200, the template 299, the greater trochanter guide 370, and the acetabular resection guide 410 can be formed of materials that are relatively inexpensive, and can be used for a single procedure on the SSP. Generally, the guide patient-specific devices can be used on the SSP in performing the planned procedure and then discarded. In discarding the patient-specific devices, it can be ensured that the patient-specific devices are specific to the SSP to achieve a planned result. Additionally, chances of cross contamination from one patient to another due to reuse of the instrument can be substantially eliminated. Additionally, a requirement of maintaining a selection and inventory of instruments and guides and labor and instrumentation for cleaning instruments and guides is not required by a facility. Generally, the patient-specific devices can be formed for each procedure based upon the data provided to the manufacture that is based on the SSP and then the patient-specific devices can then be discarded.


It is also understood that all of the guides 200, 200′, 370, and 410 along with the template 299 can be provided to together as a single kit 450 to the surgeon, along with the ancillary portions including the reamer 250 and pins 230 and 236. Also, the kit 450 can include any implants, such as screws 452 to fit in the passages 382-386. Thus, the entire kit 450 can be provided to a surgeon as illustrated in FIG. 13. The kit 450 can be sterilized and sent to the surgeon in block 126. It will be further understood, however, that the kit 450 need not include all portions. For example, the kit 450 may only include one of the femoral defect guides 200, 200′, or 299. In an alternative the kit 450 may include at least two or three of the guides for selection by the surgeon intraoperatively of the guide and/or template to be used. Also, the kit 450 may not include the acetabular guide 410. IN addition, the kit need not include the greater trochanter cut guide 370. For example, the surgeon may free hand cut the greater trochanter 28. If the greater trochanter guide 370 is not included, the screws 452 can be included for use in fixation of the resected greater trochanter 28 even if resected without the guide 370. Thus, some portions are optional, but may also be included in the kit 450.


It will be apparent to those skilled in the art that specific details need not be employed, that example embodiments may be embodied in many different forms and that neither should be construed to limit the scope of the disclosure. In some example embodiments, well-known processes, well-known device structures, and well-known technologies are not described in detail. Accordingly, individual elements or features of a particular embodiment are generally not limited to that particular embodiment, but, where applicable, are interchangeable and can be used in a selected embodiment, even if not specifically shown or described. The same may also be varied in many ways. Such variations are not to be regarded as a departure from the disclosure, and all such modifications are intended to be included within the scope of the disclosure.

Claims
  • 1. A system to resect a selected portion of an anatomy to improve a range of motion of a femur relative to a pelvis in a specific patient, comprising: a patient specific tissue removal template having a template region shaped to an inverse of a predetermined region of tissue to be removed;wherein the predetermined region of tissue to be removed is based upon an analysis of the anatomy of the specific patient.
  • 2. The system of claim 1, wherein the patient specific tissue removal template has the template region shaped to match a portion of a determined resection shape at a femoral neck of the anatomy and operable to contact the femur to analyze a resection of the femur.
  • 3. The system of claim 1, wherein the patient specific tissue removal template further includes femur contacting tangs to align the template region relative to the femur of the anatomy.
  • 4. The system of claim 3, wherein the tangs extend a distance from the template region.
  • 5. The system of claim 3, wherein the femur contacting tangs comprise: a first tang having a first curved tip to define a first contact edge;a second tang spaced from the first tang and having a second curved tip to define a second contact edge; andan indentation between the first tang and the second tang to allow the first and second tangs to fit around anatomy of the femur.
  • 6. The system of claim 3, wherein the patient specific removal template comprises: a plate defining the femur contacting tangs; anda protrusion extending from the plate to define the template region.
  • 7. The system of claim 6, wherein the protrusion extends from the plate a distance equal to a depth of bone to be removed from the femoral neck sufficient to allow articulation of a femoral head within an acetabulum without impingement of the femoral neck.
  • 8. The system of claim 3, wherein the femur contacting tangs comprise: a first pair of tangs extending from the template region in a first direction and shaped to contact a femoral head of the femur; anda second pair of tangs extending from the template region in a second direction opposite the first direction and shaped to contact a greater trochanter of the femur.
  • 9. The system of claim 1, further comprising: a femoral neck resection guide including: a bone contacting surface that mates with a surface of the femur;an exterior surface opposite the bone contacting surface;a pin extending from the exterior surface;a guide surface defined by at least a portion of the exterior surface; anda guide arm moveably connected to the pin including a guide arm surface configured to contact the guide surface during movement of the guide arm relative to the exterior surface;wherein the guide arm includes a mill passage to engage a mill instrument that is configured to resect the selected portion of the femur.
  • 10. The system of claim 1, further comprising: a greater trochanter guide including an anatomy contacting surface that is a negative of and operable to contact an anatomy of the specific patient in a substantially single position, wherein the greater trochanter guide includes: a cutting guide slot configured to be positioned at a patient specific location relative to the femur of the patient; anda drill guide portion operable to orient a drill guide passage at a specific location relative to the femur of the patient.
  • 11. The system of claim 1, wherein the patient specific tissue removal template further comprises a handle portion extending from the template region.
  • 12. A tissue removal template for performing a femoral acetabular impingement procedure on a hip joint, the tissue removal template comprising: a handle shaft;a base plate comprising: a central portion connected to the handle shaft;a first contact portion extending from a first end of the central portion to engage a first portion of the hip joint; anda second contact portion extending from a second end of the central portion opposite the first contact portion to engage a second portion of the hip joint; anda protrusion extending from the central portion opposite the handle to a length sufficient to allow a femoral head to fully articulate within a pelvis of the hip joint.
  • 13. The tissue removal template of claim 12, wherein the protrusion comprises an inverse of a region of tissue to he removed from the hip joint.
  • 14. The tissue removal template of claim 13, wherein the protrusion matches a predetermined region of tissue to be removed that is based upon an analysis of anatomy of a specific patient.
  • 15. The tissue removal template of claim 12, wherein the protrusion is shaped as an inverse of a shape of an abnormality on a neck of the femoral head.
  • 16. The tissue removal template of claim 12, wherein: the first contact portion is configured to provide a first pair of point contacts against the first portion of the hip joint, the first portion comprising a femoral head of the hip joint; andthe second contact portion is configured to provide a second pair of point contacts against the second portion of the hip joint, the second portion comprising a greater trochanter of the hip joint.
  • 17. The tissue removal template of claim 16, wherein the first and second pairs of point contacts each comprise a pair of fingers extending from the central portion.
  • 18. The tissue removal template of claim 16, further comprising: a first notch located between the first pair of point contacts configured to provide clearance for a portion of the femoral head; anda second notch located between the second pair of point contacts configured to provide clearance for a portion of the greater trochanter.
  • 19. A tissue removal template comprising: a bone referencing portion configured to contact unaltered bone landmarks;a template portion extending from the bone referencing portion configured to flushly engage a reamed bone surface between the unaltered bone landmarks, wherein the template portion comprises a protrusion having a volume configured to fill a void between the unaltered bone landmarks where a bone abnormality has been removed; anda handle shaft extending from the bone referencing portion opposite the template portion.
  • 20. The tissue removal template of claim 19, wherein: the bone referencing portion is configured to extend from a femoral head to a greater trochanter of a femur of a hip joint; andthe protrusion is configured to have a depth between a bone-engaging surface of the protrusion and a plane extending across the bone referencing portion sufficient to allow articulation of the femoral head within an acetabulum of the hip joint without impingement from the femoral neck.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of U.S. Provisional Application No. 61/540,857, filed on Sep. 29, 2011. The entire disclosure(s) of (each of) the above application(s) is (are) incorporated herein by reference.

US Referenced Citations (1122)
Number Name Date Kind
1480285 Moore Jan 1924 A
2181746 Siebrandt Nov 1939 A
2407845 Orisan Sep 1946 A
2416228 Sheppard Feb 1947 A
2618913 Plancon et al. Nov 1952 A
2910978 Urist Nov 1959 A
3330611 Heifetz Jul 1967 A
3840904 Tronzo Oct 1974 A
3975858 Much Aug 1976 A
4246895 Rehder Jan 1981 A
4306866 Weissman Dec 1981 A
4324006 Charnley Apr 1982 A
4421112 Mains et al. Dec 1983 A
4436684 White Mar 1984 A
4457306 Borzone Jul 1984 A
4475549 Oh Oct 1984 A
4506393 Murphy Mar 1985 A
4524766 Petersen Jun 1985 A
4565191 Slocum Jan 1986 A
4619658 Pappas et al. Oct 1986 A
4621630 Kenna Nov 1986 A
4632111 Roche Dec 1986 A
4633862 Petersen Jan 1987 A
4663720 Duret et al. May 1987 A
4689984 Kellner Sep 1987 A
4695283 Aldinger Sep 1987 A
4696292 Heiple Sep 1987 A
4703751 Pohl Nov 1987 A
4704686 Aldinger Nov 1987 A
4706660 Petersen Nov 1987 A
4719907 Banko et al. Jan 1988 A
4721104 Kaufman et al. Jan 1988 A
4722330 Russell et al. Feb 1988 A
4759350 Dunn et al. Jul 1988 A
4778474 Homsy Oct 1988 A
4800874 David et al. Jan 1989 A
4821213 Cline et al. Apr 1989 A
4822365 Walker et al. Apr 1989 A
4841975 Woolson Jun 1989 A
4846161 Roger Jul 1989 A
4871975 Nawata et al. Oct 1989 A
4892545 Day et al. Jan 1990 A
4893619 Dale et al. Jan 1990 A
4896663 Vandewalls Jan 1990 A
4907577 Wu Mar 1990 A
4927422 Engelhardt May 1990 A
4936862 Walker et al. Jun 1990 A
4952213 Bowman et al. Aug 1990 A
4959066 Dunn et al. Sep 1990 A
4976737 Leake Dec 1990 A
4979949 Matsen, III et al. Dec 1990 A
4985037 Petersen Jan 1991 A
5002579 Copf et al. Mar 1991 A
5006121 Hafeli Apr 1991 A
5007936 Woolson Apr 1991 A
5019105 Wiley May 1991 A
5030219 Matsen, III et al. Jul 1991 A
5030221 Buechel et al. Jul 1991 A
5041117 Engelhardt Aug 1991 A
5053037 Lackey et al. Oct 1991 A
5053039 Hofmann et al. Oct 1991 A
5056351 Stiver et al. Oct 1991 A
5086401 Glassman et al. Feb 1992 A
5098383 Hemmy et al. Mar 1992 A
5098436 Ferrante et al. Mar 1992 A
5108425 Hwang Apr 1992 A
5122144 Bert et al. Jun 1992 A
5123927 Duncan et al. Jun 1992 A
5129908 Petersen Jul 1992 A
5129909 Sutherland Jul 1992 A
5133760 Petersen et al. Jul 1992 A
5140777 Ushiyama et al. Aug 1992 A
5150304 Berchem et al. Sep 1992 A
5176684 Ferrante et al. Jan 1993 A
5176711 Grimes Jan 1993 A
5194066 Van Zile Mar 1993 A
5234433 Bert et al. Aug 1993 A
5246444 Schreiber Sep 1993 A
5253506 Davis et al. Oct 1993 A
5258032 Bertin Nov 1993 A
5274565 Reuben Dec 1993 A
5282802 Mahony, III Feb 1994 A
5299288 Glassman et al. Mar 1994 A
5300077 Howell Apr 1994 A
5320529 Pompa Jun 1994 A
5320625 Bertin Jun 1994 A
5323697 Schrock Jun 1994 A
5342366 Whiteside et al. Aug 1994 A
5344423 Dietz et al. Sep 1994 A
5360446 Kennedy Nov 1994 A
5364402 Mumme et al. Nov 1994 A
5368858 Hunziker Nov 1994 A
5370692 Fink et al. Dec 1994 A
5370699 Hood et al. Dec 1994 A
5405395 Coates Apr 1995 A
5408409 Glassman et al. Apr 1995 A
5411521 Putnam et al. May 1995 A
5415662 Ferrante et al. May 1995 A
5417694 Marik et al. May 1995 A
5438263 Dworkin et al. Aug 1995 A
5440496 Andersson et al. Aug 1995 A
5448489 Reuben Sep 1995 A
5449360 Schreiber Sep 1995 A
5452407 Crook Sep 1995 A
5454816 Ashby Oct 1995 A
5462550 Dietz et al. Oct 1995 A
5472415 King et al. Dec 1995 A
5474559 Bertin et al. Dec 1995 A
5490854 Fisher et al. Feb 1996 A
5496324 Barnes Mar 1996 A
5507833 Bohn Apr 1996 A
5514519 Neckers May 1996 A
5520695 Luckman May 1996 A
5527317 Ashby et al. Jun 1996 A
5539649 Walsh et al. Jul 1996 A
5540695 Levy Jul 1996 A
5545222 Bonutti Aug 1996 A
5549688 Ries et al. Aug 1996 A
5554190 Draenert Sep 1996 A
5560096 Stephens Oct 1996 A
5571110 Matsen, III et al. Nov 1996 A
5578037 Sanders et al. Nov 1996 A
5593411 Stalcup et al. Jan 1997 A
5595703 Swaelens et al. Jan 1997 A
5601565 Huebner Feb 1997 A
5607431 Dudasik et al. Mar 1997 A
5611802 Samuelson et al. Mar 1997 A
5613969 Jenkins, Jr. Mar 1997 A
5620448 Puddu Apr 1997 A
5634927 Houston et al. Jun 1997 A
5641323 Caldarise Jun 1997 A
5653714 Dietz et al. Aug 1997 A
5658294 Sederholm Aug 1997 A
5662656 White Sep 1997 A
5662710 Bonutti Sep 1997 A
5671018 Ohara et al. Sep 1997 A
5676668 McCue et al. Oct 1997 A
5677107 Neckers Oct 1997 A
5681354 Eckhoff Oct 1997 A
5682886 Delp et al. Nov 1997 A
5683469 Johnson et al. Nov 1997 A
5690635 Matsen, III et al. Nov 1997 A
5697933 Gundlapalli et al. Dec 1997 A
5702460 Carls et al. Dec 1997 A
5702464 Lackey et al. Dec 1997 A
5704941 Jacober et al. Jan 1998 A
5709689 Ferrante et al. Jan 1998 A
5720752 Elliot et al. Feb 1998 A
5722978 Jenkins, Jr. Mar 1998 A
5725376 Poirier Mar 1998 A
5725593 Caracciolo Mar 1998 A
5735277 Schuster Apr 1998 A
5745834 Bampton et al. Apr 1998 A
5748767 Raab May 1998 A
5749875 Puddu May 1998 A
5749876 Duvillier et al. May 1998 A
5762125 Mastrorio Jun 1998 A
5766251 Koshino Jun 1998 A
5768134 Swaelens et al. Jun 1998 A
5769092 Williamson, Jr. Jun 1998 A
5776200 Johnson et al. Jul 1998 A
5786217 Tubo et al. Jul 1998 A
5792143 Samuelson et al. Aug 1998 A
5798924 Eufinger et al. Aug 1998 A
5799055 Peshkin et al. Aug 1998 A
5835619 Morimoto et al. Nov 1998 A
5860981 Bertin et al. Jan 1999 A
5871018 Delp et al. Feb 1999 A
5876456 Sederholm et al. Mar 1999 A
5879398 Swarts et al. Mar 1999 A
5879402 Lawes et al. Mar 1999 A
5879404 Bateman et al. Mar 1999 A
5880976 DiGioia III et al. Mar 1999 A
5885297 Matsen Mar 1999 A
5885298 Herrington et al. Mar 1999 A
5888219 Bonutti Mar 1999 A
5895389 Schenk et al. Apr 1999 A
5899907 Johnson May 1999 A
5901060 Schall et al. May 1999 A
5911724 Wehrli Jun 1999 A
5925049 Gustilo et al. Jul 1999 A
5925077 Williamson et al. Jul 1999 A
5942370 Neckers Aug 1999 A
5967777 Klein et al. Oct 1999 A
5976149 Masini Nov 1999 A
5980526 Johnson et al. Nov 1999 A
6008433 Stone Dec 1999 A
6019767 Howell Feb 2000 A
6033415 Mittelstadt et al. Mar 2000 A
6042612 Voydeville Mar 2000 A
6059789 Dinger May 2000 A
6059833 Doets May 2000 A
6066175 Henderson et al. May 2000 A
6086593 Bonutti Jul 2000 A
6120510 Albrektsson et al. Sep 2000 A
6120544 Grundei et al. Sep 2000 A
6126690 Ateshian et al. Oct 2000 A
6126692 Robie et al. Oct 2000 A
6132469 Schroeder Oct 2000 A
6136033 Suemer Oct 2000 A
6156069 Amstutz Dec 2000 A
6159217 Robie et al. Dec 2000 A
6161080 Aouni-Ateshian et al. Dec 2000 A
6162257 Gustilo et al. Dec 2000 A
6187010 Masini Feb 2001 B1
6195615 Lysen Feb 2001 B1
6203546 Macmahon Mar 2001 B1
6205411 Digioia, III et al. Mar 2001 B1
6206927 Fell et al. Mar 2001 B1
6210445 Zawadzki Apr 2001 B1
6238435 Meulink et al. May 2001 B1
6254604 Howell Jul 2001 B1
6258097 Cook et al. Jul 2001 B1
6264698 Lawes et al. Jul 2001 B1
6270529 Terrill-Grisoni et al. Aug 2001 B1
6273891 Masini Aug 2001 B1
6290727 Otto et al. Sep 2001 B1
6293971 Nelson et al. Sep 2001 B1
6302913 Ripamonti et al. Oct 2001 B1
6310269 Friese et al. Oct 2001 B1
6312258 Ashman Nov 2001 B1
6312473 Oshida Nov 2001 B1
6319285 Chamier et al. Nov 2001 B1
6322728 Brodkin et al. Nov 2001 B1
6325829 Schmotzer Dec 2001 B1
6327491 Franklin et al. Dec 2001 B1
6343987 Hayama et al. Feb 2002 B2
6354011 Albrecht Mar 2002 B1
6361563 Terrill-Grisoni et al. Mar 2002 B2
6379299 Borodulin et al. Apr 2002 B1
6379388 Ensign et al. Apr 2002 B1
6383228 Schmotzer May 2002 B1
6391251 Keicher et al. May 2002 B1
6395005 Lovell May 2002 B1
6416553 White et al. Jul 2002 B1
6424332 Powell Jul 2002 B1
6427698 Yoon et al. Aug 2002 B1
6459948 Ateshian et al. Oct 2002 B1
6463351 Clynch Oct 2002 B1
6475243 Sheldon et al. Nov 2002 B1
6482236 Habecker Nov 2002 B2
6488715 Pope et al. Dec 2002 B1
6503255 Albrektsson et al. Jan 2003 B1
6508980 Sachs et al. Jan 2003 B1
6510334 Schuster et al. Jan 2003 B1
6514259 Picard et al. Feb 2003 B2
6517583 Pope et al. Feb 2003 B1
6519998 Ertl et al. Feb 2003 B2
6520964 Tallarida et al. Feb 2003 B2
6533737 Brosseau et al. Mar 2003 B1
6547823 Scarborough et al. Apr 2003 B2
6551325 Neubauer et al. Apr 2003 B2
6554837 Hauri et al. Apr 2003 B1
6556008 Thesen Apr 2003 B2
6558391 Axelson, Jr. et al. May 2003 B2
6558428 Park May 2003 B2
6562073 Foley May 2003 B2
6564085 Meaney et al. May 2003 B2
6567681 Lindequist May 2003 B1
6575980 Robie et al. Jun 2003 B1
6575982 Bonutti Jun 2003 B1
6591581 Schmieding Jul 2003 B2
6605293 Giordano et al. Aug 2003 B1
6610067 Tallarida et al. Aug 2003 B2
6622567 Hamel et al. Sep 2003 B1
6629999 Serafin, Jr. Oct 2003 B1
6641617 Merrill et al. Nov 2003 B1
6676892 Das et al. Jan 2004 B2
6682566 Draenert et al. Jan 2004 B2
6682567 Schroeder Jan 2004 B1
6696073 Boyce et al. Feb 2004 B2
6697664 Kienzle III et al. Feb 2004 B2
6701174 Krause et al. Mar 2004 B1
6709462 Hanssen Mar 2004 B2
6711431 Sarin et al. Mar 2004 B2
6711432 Krause et al. Mar 2004 B1
6712856 Carignan et al. Mar 2004 B1
6716249 Hyde Apr 2004 B2
6725077 Balloni et al. Apr 2004 B1
6738657 Franklin et al. May 2004 B1
6740092 Lombardo et al. May 2004 B2
6749638 Saladiono Jun 2004 B1
6750653 Zou et al. Jun 2004 B1
6772026 Bradbury et al. Aug 2004 B2
6780190 Maroney Aug 2004 B2
6786930 Biscup Sep 2004 B2
6799066 Steines et al. Sep 2004 B2
6823871 Schmieding Nov 2004 B2
6827723 Carson Dec 2004 B2
6887247 Couture et al. May 2005 B1
6905514 Carignan et al. Jun 2005 B2
6916324 Sanford Jul 2005 B2
6923817 Carson et al. Aug 2005 B2
6923831 Fell et al. Aug 2005 B2
6932842 Litschko et al. Aug 2005 B1
6942475 Ensign et al. Sep 2005 B2
6944518 Roose Sep 2005 B2
6945976 Ball et al. Sep 2005 B2
6953480 Mears et al. Oct 2005 B2
6960216 Kolb et al. Nov 2005 B2
6966932 Schroeder Nov 2005 B1
6975755 Baumberg Dec 2005 B1
6990220 Ellis et al. Jan 2006 B2
6993406 Cesarano, III et al. Jan 2006 B1
7001385 Bonutti Feb 2006 B2
7029479 Tallarida et al. Apr 2006 B2
7042222 Zheng et al. May 2006 B2
7048741 Swanson May 2006 B2
7050877 Iseki et al. May 2006 B2
7060074 Rosa et al. Jun 2006 B2
7074241 Mckinnon Jul 2006 B2
RE39301 Bertin Sep 2006 E
7104995 Crofford Sep 2006 B2
7104997 Lionberger et al. Sep 2006 B2
7105026 Johnson et al. Sep 2006 B2
7115131 Engh et al. Oct 2006 B2
7121832 Hsieh et al. Oct 2006 B2
7141053 Rosa et al. Nov 2006 B2
D533664 Büttler et al. Dec 2006 S
7169185 Sidebotham Jan 2007 B2
7174282 Hollister et al. Feb 2007 B2
7176466 Rousso et al. Feb 2007 B2
7184814 Lang et al. Feb 2007 B2
7198628 Ondrla et al. Apr 2007 B2
7218232 Disilvestro et al. May 2007 B2
7220264 Hershberger May 2007 B1
7239908 Alexander et al. Jul 2007 B1
7241315 Evans Jul 2007 B2
7255702 Serra et al. Aug 2007 B2
7258701 Aram et al. Aug 2007 B2
7275218 Petrella et al. Sep 2007 B2
7282054 Steffensmeier et al. Oct 2007 B2
7294133 Zink et al. Nov 2007 B2
7297164 Johnson et al. Nov 2007 B2
7309339 Cusick et al. Dec 2007 B2
7333013 Berger Feb 2008 B2
7335206 Steffensmeier et al. Feb 2008 B2
7335207 Smith Feb 2008 B1
7335231 Mclean Feb 2008 B2
7371260 Malinin May 2008 B2
7383164 Aram et al. Jun 2008 B2
7385498 Dobosz Jun 2008 B2
7388972 Kitson Jun 2008 B2
7390327 Collazo et al. Jun 2008 B2
7392076 Moctezuma De La Barrera Jun 2008 B2
7427200 Noble et al. Sep 2008 B2
7427272 Richard et al. Sep 2008 B2
7468075 Lang et al. Dec 2008 B2
7474223 Nycz et al. Jan 2009 B2
7488325 Qian et al. Feb 2009 B2
7517365 Carignan et al. Apr 2009 B2
7519540 Mayaud Apr 2009 B2
7527631 Maroney et al. May 2009 B2
7534263 Burdulis, Jr. et al. May 2009 B2
7537664 O'neill et al. May 2009 B2
7542791 Mire et al. Jun 2009 B2
7559931 Stone Jul 2009 B2
7575602 Amirouche et al. Aug 2009 B2
7578851 Dong et al. Aug 2009 B2
7582091 Duncan et al. Sep 2009 B2
7591821 Kleman Sep 2009 B2
7601155 Petersen Oct 2009 B2
7603192 Martin et al. Oct 2009 B2
7604639 Swanson Oct 2009 B2
7611516 Maroney Nov 2009 B2
7618451 Berez et al. Nov 2009 B2
7621915 Frederick et al. Nov 2009 B2
7625409 Saltzman et al. Dec 2009 B2
7646161 Albu-schäffer et al. Jan 2010 B2
7651501 Penenberg et al. Jan 2010 B2
7670345 Plassky et al. Mar 2010 B2
7682398 Croxton et al. Mar 2010 B2
7695476 Nevelos et al. Apr 2010 B2
7695477 Creger et al. Apr 2010 B2
7695521 Ely et al. Apr 2010 B2
7699847 Sheldon et al. Apr 2010 B2
7704253 Bastian et al. Apr 2010 B2
7714927 Terashima May 2010 B2
7723395 Ringeisen et al. May 2010 B2
7747305 Dean et al. Jun 2010 B2
D622854 Otto et al. Aug 2010 S
7780672 Metzger et al. Aug 2010 B2
7780740 Steinberg Aug 2010 B2
7789885 Metzger Sep 2010 B2
7794466 Merchant Sep 2010 B2
7794467 McGinley et al. Sep 2010 B2
7794504 Case Sep 2010 B2
7806896 Bonutti Oct 2010 B1
7809184 Neubauer et al. Oct 2010 B2
7819925 King et al. Oct 2010 B2
7828806 Graf et al. Nov 2010 B2
7833245 Kaes et al. Nov 2010 B2
7837690 Metzger Nov 2010 B2
7850698 Straszheim-Morley et al. Dec 2010 B2
7879109 Borden et al. Feb 2011 B2
7892261 Bonutti Feb 2011 B2
7896921 Smith et al. Mar 2011 B2
7926363 Miller et al. Apr 2011 B2
7935119 Ammann et al. May 2011 B2
7935150 Carignan et al. May 2011 B2
7938861 King et al. May 2011 B2
7959637 Fox et al. Jun 2011 B2
7962196 Tuma Jun 2011 B2
7963968 Dees, Jr. Jun 2011 B2
7967823 Ammann et al. Jun 2011 B2
7967868 White et al. Jun 2011 B2
7974677 Mire et al. Jul 2011 B2
7981158 Fitz et al. Jul 2011 B2
7988736 May et al. Aug 2011 B2
7993353 Roßner et al. Aug 2011 B2
8062301 Ammann et al. Nov 2011 B2
8066708 Lang et al. Nov 2011 B2
8070752 Metzger et al. Dec 2011 B2
8083745 Lang et al. Dec 2011 B2
8083746 Novak Dec 2011 B2
8083749 Taber Dec 2011 B2
8086336 Christensen Dec 2011 B2
8092465 Metzger et al. Jan 2012 B2
8105330 Fitz et al. Jan 2012 B2
8122582 Burdulis, Jr. et al. Feb 2012 B2
8133230 Stevens et al. Mar 2012 B2
8133234 Meridew et al. Mar 2012 B2
8137406 Novak et al. Mar 2012 B2
8147861 Jones et al. Apr 2012 B2
8160345 Pavlovskaia et al. Apr 2012 B2
8167951 Ammann et al. May 2012 B2
8170641 Belcher May 2012 B2
8182489 Horacek May 2012 B2
8192441 Collazo Jun 2012 B2
8192495 Simpson et al. Jun 2012 B2
8200355 Lee et al. Jun 2012 B2
8211112 Novak et al. Jul 2012 B2
8221430 Park et al. Jul 2012 B2
8241292 Collazo Aug 2012 B2
8241293 Stone et al. Aug 2012 B2
8246680 Betz et al. Aug 2012 B2
8260589 Kumar Sep 2012 B1
8265790 Amiot et al. Sep 2012 B2
8268099 O'neill et al. Sep 2012 B2
8268100 O'neill et al. Sep 2012 B2
D669176 Frey Oct 2012 S
8282646 Schoenfeld et al. Oct 2012 B2
8298237 Schoenfeld et al. Oct 2012 B2
8303596 Plaßky et al. Nov 2012 B2
8313491 Green, II et al. Nov 2012 B2
D672038 Frey Dec 2012 S
8333772 Fox et al. Dec 2012 B2
8337503 Lian Dec 2012 B2
8355773 Leitner et al. Jan 2013 B2
8372078 Collazo Feb 2013 B2
8377066 Katrana et al. Feb 2013 B2
8388690 Singhatat et al. Mar 2013 B2
8398646 Metzger et al. Mar 2013 B2
8407067 Uthgenannt et al. Mar 2013 B2
8414594 Berger et al. Apr 2013 B2
8419741 Carignan et al. Apr 2013 B2
8425522 Bonutti Apr 2013 B2
8430882 Lowry et al. Apr 2013 B2
8430931 Acker et al. Apr 2013 B2
8439675 De Moyer May 2013 B2
8439925 Marino et al. May 2013 B2
8444564 Mahfouz et al. May 2013 B2
8444651 Kunz et al. May 2013 B2
8457930 Schroeder Jun 2013 B2
8460302 Park et al. Jun 2013 B2
8469961 Alleyne et al. Jun 2013 B2
8473305 Belcher et al. Jun 2013 B2
8486150 White et al. Jul 2013 B2
8500740 Bojarski et al. Aug 2013 B2
8532361 Pavlovskala et al. Sep 2013 B2
8532806 Masson Sep 2013 B1
8532807 Metzger Sep 2013 B2
8535387 Meridew et al. Sep 2013 B2
8543234 Gao Sep 2013 B2
8545508 Collazo Oct 2013 B2
8568487 Witt et al. Oct 2013 B2
8591516 Metzger et al. Nov 2013 B2
8597365 Meridew Dec 2013 B2
8603180 White et al. Dec 2013 B2
8608748 Metzger et al. Dec 2013 B2
8608749 Meridew et al. Dec 2013 B2
8617170 Ashby et al. Dec 2013 B2
8617174 Axelson, Jr. et al. Dec 2013 B2
8617175 Park et al. Dec 2013 B2
8632547 Maxson et al. Jan 2014 B2
8652142 Geissler Feb 2014 B2
8668700 Catanzarite et al. Mar 2014 B2
8702712 Jordan et al. Apr 2014 B2
8702715 Ammann et al. Apr 2014 B2
8706285 Narainasamy et al. Apr 2014 B2
8715289 Smith May 2014 B2
8728387 Jones et al. May 2014 B2
8735773 Lang May 2014 B2
8764760 Metzger et al. Jul 2014 B2
8775133 Schroeder Jul 2014 B2
8777875 Park Jul 2014 B2
8828016 Major et al. Sep 2014 B2
8828087 Stone et al. Sep 2014 B2
8828089 Perez et al. Sep 2014 B1
8834568 Shapiro Sep 2014 B2
8858561 White et al. Oct 2014 B2
8864769 Stone et al. Oct 2014 B2
8900244 Meridew et al. Dec 2014 B2
8903530 Metzger Dec 2014 B2
8956364 Catanzarite Feb 2015 B2
8979936 White et al. Mar 2015 B2
9005297 Katrana et al. Apr 2015 B2
9386993 Meridew et al. Jul 2016 B2
20010005797 Barlow et al. Jun 2001 A1
20010011190 Park Aug 2001 A1
20010021876 Terril-Grisoni et al. Sep 2001 A1
20010054478 Watanabe et al. Dec 2001 A1
20020007294 Bradbury et al. Jan 2002 A1
20020029045 Bonutti Mar 2002 A1
20020052606 Bonutti May 2002 A1
20020059049 Bradbury et al. May 2002 A1
20020082741 Mazumder et al. Jun 2002 A1
20020087274 Alexander et al. Jul 2002 A1
20020107522 Picard et al. Aug 2002 A1
20020111690 Hyde Aug 2002 A1
20020120342 Gibbs Aug 2002 A1
20020128872 Giammattei Sep 2002 A1
20020147415 Martelli Oct 2002 A1
20020186818 Arnaud et al. Dec 2002 A1
20020193797 Johnson et al. Dec 2002 A1
20020198528 Engh et al. Dec 2002 A1
20020198531 Millard et al. Dec 2002 A1
20030009171 Tornier Jan 2003 A1
20030009234 Treacy et al. Jan 2003 A1
20030011624 Ellis Jan 2003 A1
20030018338 Stuart, Jr. et al. Jan 2003 A1
20030039676 Boyce et al. Feb 2003 A1
20030055502 Lang et al. Mar 2003 A1
20030105526 Bryant et al. Jun 2003 A1
20030109784 Loh et al. Jun 2003 A1
20030120276 Tallarida et al. Jun 2003 A1
20030130741 McMinn Jul 2003 A1
20030139817 Tuke et al. Jul 2003 A1
20030158606 Coon et al. Aug 2003 A1
20030171757 Coon et al. Sep 2003 A1
20030212459 Gibbs Nov 2003 A1
20030216669 Lang et al. Nov 2003 A1
20040018144 Briscoe Jan 2004 A1
20040030245 Noble et al. Feb 2004 A1
20040054372 Corden et al. Mar 2004 A1
20040054416 Wyss et al. Mar 2004 A1
20040068187 Krause et al. Apr 2004 A1
20040092932 Aubin et al. May 2004 A1
20040098133 Carignan et al. May 2004 A1
20040102852 Johnson et al. May 2004 A1
20040102866 Harris et al. May 2004 A1
20040106926 Leitner et al. Jun 2004 A1
20040115586 Andreiko et al. Jun 2004 A1
20040122436 Grimm Jun 2004 A1
20040122439 Dwyer et al. Jun 2004 A1
20040128026 Harris et al. Jul 2004 A1
20040133276 Lang et al. Jul 2004 A1
20040138754 Lang et al. Jul 2004 A1
20040143336 Burkinshaw Jul 2004 A1
20040147927 Tsougarakis et al. Jul 2004 A1
20040148026 Bonutti Jul 2004 A1
20040153079 Tsougarakis et al. Aug 2004 A1
20040153087 Sanford et al. Aug 2004 A1
20040158254 Eisermann Aug 2004 A1
20040162619 Blaylock et al. Aug 2004 A1
20040167390 Alexander et al. Aug 2004 A1
20040171924 Mire et al. Sep 2004 A1
20040172137 Blaylock et al. Sep 2004 A1
20040181144 Cinquin et al. Sep 2004 A1
20040193169 Schon et al. Sep 2004 A1
20040204644 Tsougarakis et al. Oct 2004 A1
20040204760 Fitz et al. Oct 2004 A1
20040212586 Trueman, III Oct 2004 A1
20040220583 Pieczynski, II et al. Nov 2004 A1
20040225369 Lakin et al. Nov 2004 A1
20040236341 Petersen Nov 2004 A1
20040236424 Berez et al. Nov 2004 A1
20040243481 Bradbury et al. Dec 2004 A1
20040254584 Sarin et al. Dec 2004 A1
20040260301 Lionberger et al. Dec 2004 A1
20050008887 Haymann et al. Jan 2005 A1
20050010227 Paul Jan 2005 A1
20050010300 Disilvestro et al. Jan 2005 A1
20050015022 Richard et al. Jan 2005 A1
20050019664 Matsumoto Jan 2005 A1
20050021148 Gibbs Jan 2005 A1
20050027303 Lionberger et al. Feb 2005 A1
20050027361 Reiley Feb 2005 A1
20050043806 Cook et al. Feb 2005 A1
20050043837 Rubbert et al. Feb 2005 A1
20050049524 Lefevre et al. Mar 2005 A1
20050049603 Calton et al. Mar 2005 A1
20050059873 Glozman et al. Mar 2005 A1
20050060040 Auxepaules et al. Mar 2005 A1
20050065628 Roose Mar 2005 A1
20050070897 Petersen Mar 2005 A1
20050071015 Sekel Mar 2005 A1
20050075641 Singhatat et al. Apr 2005 A1
20050096535 De la Barrera May 2005 A1
20050113841 Sheldon et al. May 2005 A1
20050113846 Carson May 2005 A1
20050119664 Carignan et al. Jun 2005 A1
20050131662 Ascenzi et al. Jun 2005 A1
20050137708 Clark Jun 2005 A1
20050143746 Steffensmeier et al. Jun 2005 A1
20050148843 Roose Jul 2005 A1
20050149042 Metzger Jul 2005 A1
20050165420 Cha Jul 2005 A1
20050171545 Walsh et al. Aug 2005 A1
20050177245 Leatherbury et al. Aug 2005 A1
20050197661 Carrison Sep 2005 A1
20050203536 Laffargue et al. Sep 2005 A1
20050203540 Broyles Sep 2005 A1
20050209605 Grimm et al. Sep 2005 A1
20050216305 Funderud Sep 2005 A1
20050222571 Ryan Oct 2005 A1
20050222573 Branch et al. Oct 2005 A1
20050228393 Williams et al. Oct 2005 A1
20050234461 Burdulis, Jr. et al. Oct 2005 A1
20050234465 Mccombs et al. Oct 2005 A1
20050234468 Carson Oct 2005 A1
20050240195 Axelson, Jr. et al. Oct 2005 A1
20050240267 Randall et al. Oct 2005 A1
20050244239 Shimp Nov 2005 A1
20050245934 Tuke et al. Nov 2005 A1
20050245936 Tuke et al. Nov 2005 A1
20050251147 Novak Nov 2005 A1
20050267353 Marquart et al. Dec 2005 A1
20050267485 Cordes et al. Dec 2005 A1
20050267584 Burdulis, Jr. et al. Dec 2005 A1
20050273114 Novak Dec 2005 A1
20050283252 Coon et al. Dec 2005 A1
20050283253 Coon et al. Dec 2005 A1
20060004284 Grunschlager et al. Jan 2006 A1
20060015120 Richard et al. Jan 2006 A1
20060030853 Haines Feb 2006 A1
20060038520 Negoro Feb 2006 A1
20060052725 Santilli Mar 2006 A1
20060058803 Cuckler et al. Mar 2006 A1
20060058884 Aram et al. Mar 2006 A1
20060058886 Wozencroft Mar 2006 A1
20060089621 Fard Apr 2006 A1
20060093988 Swaelens et al. May 2006 A1
20060094951 Dean et al. May 2006 A1
20060095044 Grady, Jr. et al. May 2006 A1
20060100632 Fell May 2006 A1
20060100832 Bowman May 2006 A1
20060105011 Sun et al. May 2006 A1
20060111722 Bouadi May 2006 A1
20060122616 Bennett et al. Jun 2006 A1
20060122618 Claypool et al. Jun 2006 A1
20060136058 Pietrzak Jun 2006 A1
20060142657 Quaid et al. Jun 2006 A1
20060147332 Jones et al. Jul 2006 A1
20060149283 May et al. Jul 2006 A1
20060155380 Clemow et al. Jul 2006 A1
20060161165 Swanson et al. Jul 2006 A1
20060161167 Myers et al. Jul 2006 A1
20060172263 Quadling et al. Aug 2006 A1
20060178497 Gevaert et al. Aug 2006 A1
20060184177 Echeverri Aug 2006 A1
20060184250 Bandoh et al. Aug 2006 A1
20060190086 Clemow et al. Aug 2006 A1
20060195111 Couture Aug 2006 A1
20060195194 Gunther Aug 2006 A1
20060195198 James Aug 2006 A1
20060198943 Kumar Sep 2006 A1
20060200158 Farling et al. Sep 2006 A1
20060204932 Haymann et al. Sep 2006 A1
20060210644 Levin Sep 2006 A1
20060217808 Novak Sep 2006 A1
20060235421 Rosa et al. Oct 2006 A1
20060241635 Stumpo et al. Oct 2006 A1
20060241636 Novak et al. Oct 2006 A1
20060271058 Ashton et al. Nov 2006 A1
20060276796 Creger et al. Dec 2006 A1
20060276797 Botimer Dec 2006 A1
20060287733 Bonutti Dec 2006 A1
20060287891 Grasso et al. Dec 2006 A1
20060293681 Claypool et al. Dec 2006 A1
20070015995 Lang et al. Jan 2007 A1
20070016008 Schoenefeld Jan 2007 A1
20070016209 Ammann et al. Jan 2007 A1
20070027680 Ashley et al. Feb 2007 A1
20070039205 Erb et al. Feb 2007 A1
20070043582 Peveto et al. Feb 2007 A1
20070066917 Hodorek et al. Mar 2007 A1
20070073133 Schoenefeld Mar 2007 A1
20070073136 Metzger Mar 2007 A1
20070073137 Schoenefeld Mar 2007 A1
20070083214 Duncan et al. Apr 2007 A1
20070083266 Lang Apr 2007 A1
20070100258 Shoham et al. May 2007 A1
20070100450 Hodorek May 2007 A1
20070100462 Lang et al. May 2007 A1
20070106299 Manspeizer May 2007 A1
20070106391 Ronk May 2007 A1
20070118055 Mccombs May 2007 A1
20070118138 Seo et al. May 2007 A1
20070118243 Schroeder et al. May 2007 A1
20070129809 Meridew et al. Jun 2007 A1
20070142914 Jones et al. Jun 2007 A1
20070150068 Dong et al. Jun 2007 A1
20070156066 Mcginley et al. Jul 2007 A1
20070156171 Lang et al. Jul 2007 A1
20070162038 Tuke Jul 2007 A1
20070162039 Wozencroft Jul 2007 A1
20070173946 Bonutti Jul 2007 A1
20070173948 Meridew et al. Jul 2007 A1
20070185498 Lavallee Aug 2007 A2
20070191962 Jones Aug 2007 A1
20070198022 Lang et al. Aug 2007 A1
20070203430 Lang et al. Aug 2007 A1
20070203583 Slone Aug 2007 A1
20070203605 Melton et al. Aug 2007 A1
20070219562 Slone et al. Sep 2007 A1
20070219639 Otto et al. Sep 2007 A1
20070219640 Steinberg Sep 2007 A1
20070224238 Mansmann et al. Sep 2007 A1
20070226986 Park et al. Oct 2007 A1
20070233121 Carson et al. Oct 2007 A1
20070233136 Wozencroft Oct 2007 A1
20070233140 Metzger et al. Oct 2007 A1
20070233141 Park et al. Oct 2007 A1
20070233269 Steines et al. Oct 2007 A1
20070233272 Boyce et al. Oct 2007 A1
20070238069 Lovald et al. Oct 2007 A1
20070239282 Caylor, III et al. Oct 2007 A1
20070239481 Disilvestro et al. Oct 2007 A1
20070244487 Ammann et al. Oct 2007 A1
20070250169 Lang Oct 2007 A1
20070250175 Meridew et al. Oct 2007 A1
20070253617 Arata et al. Nov 2007 A1
20070255288 Mahfouz et al. Nov 2007 A1
20070255412 Hajaj et al. Nov 2007 A1
20070262867 Westrick et al. Nov 2007 A1
20070272747 Woods et al. Nov 2007 A1
20070276224 Lang et al. Nov 2007 A1
20070276400 Moore et al. Nov 2007 A1
20070276501 Betz et al. Nov 2007 A1
20070288029 Justin et al. Dec 2007 A1
20070288030 Metzger et al. Dec 2007 A1
20080009874 Meridew et al. Jan 2008 A1
20080009952 Hodge Jan 2008 A1
20080015599 D'alessio et al. Jan 2008 A1
20080015603 Collazo Jan 2008 A1
20080015604 Callazo Jan 2008 A1
20080015605 Collazo Jan 2008 A1
20080021299 Meulink Jan 2008 A1
20080021494 Schmelzeisen-redeker et al. Jan 2008 A1
20080021567 Meulink et al. Jan 2008 A1
20080027563 Johnson et al. Jan 2008 A1
20080005191 Kammerzell et al. Feb 2008 A1
20080033442 Amiot et al. Feb 2008 A1
20080039850 Rowley et al. Feb 2008 A1
20080051799 Bonutti et al. Feb 2008 A1
20080058945 Hajaj et al. Mar 2008 A1
20080058947 Earl et al. Mar 2008 A1
20080062183 Swaelens Mar 2008 A1
20080065225 Wasielewski et al. Mar 2008 A1
20080094396 Sabczynsdi et al. Apr 2008 A1
20080097451 Chen et al. Apr 2008 A1
20080114370 Schoenefeld May 2008 A1
20080133022 Caylor Jun 2008 A1
20080140081 Heavener et al. Jun 2008 A1
20080140209 Iannotti et al. Jun 2008 A1
20080140213 Ammann et al. Jun 2008 A1
20080146969 Kurtz Jun 2008 A1
20080147072 Park et al. Jun 2008 A1
20080147073 Ammann et al. Jun 2008 A1
20080147074 Ammann et al. Jun 2008 A1
20080161815 Schoenefeld et al. Jul 2008 A1
20080161816 Stevens et al. Jul 2008 A1
20080172125 Ek Jul 2008 A1
20080195099 Minas Aug 2008 A1
20080195107 Cuckler et al. Aug 2008 A1
20080195108 Bhatnagar et al. Aug 2008 A1
20080195109 Hunter et al. Aug 2008 A1
20080195216 Philipp Aug 2008 A1
20080200926 Verard et al. Aug 2008 A1
20080208200 Crofford Aug 2008 A1
20080208353 Kumar et al. Aug 2008 A1
20080215059 Carignan et al. Sep 2008 A1
20080221699 Meridew et al. Sep 2008 A1
20080230422 Pleil et al. Sep 2008 A1
20080234664 May et al. Sep 2008 A1
20080234683 May Sep 2008 A1
20080234685 Gjerde Sep 2008 A1
20080234833 Bandoh et al. Sep 2008 A1
20080243127 Lang et al. Oct 2008 A1
20080255674 Rahaman et al. Oct 2008 A1
20080257363 Schoenefeld et al. Oct 2008 A1
20080262500 Collazo Oct 2008 A1
20080262624 White et al. Oct 2008 A1
20080269596 Revie et al. Oct 2008 A1
20080269906 Iannotti et al. Oct 2008 A1
20080275452 Lang et al. Nov 2008 A1
20080281328 Lang et al. Nov 2008 A1
20080281329 Fitz et al. Nov 2008 A1
20080281426 Fitz et al. Nov 2008 A1
20080287926 Abou El Kheir Nov 2008 A1
20080287954 Kunz et al. Nov 2008 A1
20080294170 O'brien Nov 2008 A1
20080294266 Steinberg Nov 2008 A1
20080300600 Guelat et al. Dec 2008 A1
20080306485 Coon et al. Dec 2008 A1
20080306558 Hakki Dec 2008 A1
20080312659 Metzger et al. Dec 2008 A1
20080319448 Lavallee et al. Dec 2008 A1
20090012526 Fletcher Jan 2009 A1
20090018546 Daley Jan 2009 A1
20090018666 Grundei et al. Jan 2009 A1
20090024131 Metzger et al. Jan 2009 A1
20090024169 Triplett et al. Jan 2009 A1
20090043556 Axelson et al. Feb 2009 A1
20090048618 Harrison et al. Feb 2009 A1
20090076371 Lang et al. Mar 2009 A1
20090076512 Ammann Mar 2009 A1
20090076520 Choi Mar 2009 A1
20090076555 Lowry et al. Mar 2009 A1
20090082770 Worner et al. Mar 2009 A1
20090082774 Oti et al. Mar 2009 A1
20090087276 Rose Apr 2009 A1
20090088674 Caillouette et al. Apr 2009 A1
20090088753 Aram et al. Apr 2009 A1
20090088754 Aker et al. Apr 2009 A1
20090088755 Aker et al. Apr 2009 A1
20090088758 Bennett Apr 2009 A1
20090088759 Aram et al. Apr 2009 A1
20090088760 Aram et al. Apr 2009 A1
20090088761 Roose et al. Apr 2009 A1
20090088763 Aram et al. Apr 2009 A1
20090088865 Brehm Apr 2009 A1
20090088866 Case Apr 2009 A1
20090089034 Penney et al. Apr 2009 A1
20090089081 Haddad Apr 2009 A1
20090093815 Fletcher et al. Apr 2009 A1
20090093816 Roose et al. Apr 2009 A1
20090096613 Westrick Apr 2009 A1
20090099567 Zajac Apr 2009 A1
20090105837 Lafosse et al. Apr 2009 A1
20090116621 Yuan et al. May 2009 A1
20090118736 Kreuzer May 2009 A1
20090118769 Sixto, Jr. et al. May 2009 A1
20090131941 Park et al. May 2009 A1
20090131942 Aker et al. May 2009 A1
20090138020 Park et al. May 2009 A1
20090149965 Quaid Jun 2009 A1
20090149977 Schendel Jun 2009 A1
20090151736 Belcher et al. Jun 2009 A1
20090157083 Park et al. Jun 2009 A1
20090163922 Meridew et al. Jun 2009 A1
20090163923 Flett et al. Jun 2009 A1
20090164024 Rudan et al. Jun 2009 A1
20090177282 Bureau et al. Jul 2009 A1
20090187193 Maroney et al. Jul 2009 A1
20090204225 Meridew et al. Aug 2009 A1
20090209884 Van Vorhis et al. Aug 2009 A1
20090209961 Ferrante et al. Aug 2009 A1
20090210067 Meridew Aug 2009 A1
20090222014 Bojarski et al. Sep 2009 A1
20090222015 Park et al. Sep 2009 A1
20090222016 Park et al. Sep 2009 A1
20090222103 Fitz et al. Sep 2009 A1
20090226068 Fitz et al. Sep 2009 A1
20090228016 Alvarez Sep 2009 A1
20090234360 Alexander Sep 2009 A1
20090248044 Amiot et al. Oct 2009 A1
20090250413 Hoeppner Oct 2009 A1
20090254093 White Oct 2009 A1
20090254367 Belcher et al. Oct 2009 A1
20090259312 Shterling et al. Oct 2009 A1
20090270868 Park et al. Oct 2009 A1
20090274350 Pavlovskaia et al. Nov 2009 A1
20090287217 Ammann et al. Nov 2009 A1
20090287309 Walch et al. Nov 2009 A1
20090306676 Lang et al. Dec 2009 A1
20090307893 Burdulis, Jr. et al. Dec 2009 A1
20090318836 Stone et al. Dec 2009 A1
20090318921 White et al. Dec 2009 A1
20100010493 Dower Jan 2010 A1
20100016984 Trabish Jan 2010 A1
20100016986 Trabish Jan 2010 A1
20100023015 Park Jan 2010 A1
20100030231 Revie et al. Feb 2010 A1
20100036404 Yi et al. Feb 2010 A1
20100042105 Park et al. Feb 2010 A1
20100049195 Park et al. Feb 2010 A1
20100049327 Isch et al. Feb 2010 A1
20100057088 Shah Mar 2010 A1
20100076439 Hatch Mar 2010 A1
20100076505 Borja Mar 2010 A1
20100076563 Otto et al. Mar 2010 A1
20100076571 Hatch Mar 2010 A1
20100082034 Remia Apr 2010 A1
20100082035 Keefer Apr 2010 A1
20100082067 Kondrashov Apr 2010 A1
20100087829 Metzger Apr 2010 A1
20100094295 Schnieders et al. Apr 2010 A1
20100105011 Karkar et al. Apr 2010 A1
20100114101 Crofford May 2010 A1
20100121334 Couture et al. May 2010 A1
20100121335 Penenberg et al. May 2010 A1
20100131073 Meridew et al. May 2010 A1
20100136214 Kumar Jun 2010 A1
20100137869 Borja et al. Jun 2010 A1
20100137924 Tuke et al. Jun 2010 A1
20100145343 Johnson et al. Jun 2010 A1
20100145344 Jordan et al. Jun 2010 A1
20100145466 Slone Jun 2010 A1
20100152742 Nevelos et al. Jun 2010 A1
20100152782 Stone et al. Jun 2010 A1
20100160917 Fitz et al. Jun 2010 A1
20100160919 Axelson, Jr. et al. Jun 2010 A1
20100168752 Edwards Jul 2010 A1
20100168754 Fitz et al. Jul 2010 A1
20100168857 Hatch Jul 2010 A1
20100168866 Shih Jul 2010 A1
20100179663 Steinberg Jul 2010 A1
20100185202 Lester et al. Jul 2010 A1
20100191244 White et al. Jul 2010 A1
20100198067 Mahfouz et al. Aug 2010 A1
20100198224 Metzger Aug 2010 A1
20100212138 Carroll et al. Aug 2010 A1
20100217109 Belcher Aug 2010 A1
20100217270 Polinski et al. Aug 2010 A1
20100217336 Crawford et al. Aug 2010 A1
20100217338 Carroll et al. Aug 2010 A1
20100217399 Groh Aug 2010 A1
20100228257 Bonutti Sep 2010 A1
20100249657 Nycz et al. Sep 2010 A1
20100249796 Nycz Sep 2010 A1
20100256649 Capsal et al. Oct 2010 A1
20100262150 Lian Oct 2010 A1
20100274253 Ure Oct 2010 A1
20100281678 Burdulis, Jr. et al. Nov 2010 A1
20100286700 Snider et al. Nov 2010 A1
20100286789 Meridew Nov 2010 A1
20100291401 Medina et al. Nov 2010 A1
20100292743 Singhal et al. Nov 2010 A1
20100298894 Bojarski et al. Nov 2010 A1
20100305574 Fitz et al. Dec 2010 A1
20100318088 Warne et al. Dec 2010 A1
20100324692 Uthgenannt et al. Dec 2010 A1
20110004317 Hacking et al. Jan 2011 A1
20110008754 Bassett et al. Jan 2011 A1
20110009869 Marino et al. Jan 2011 A1
20110014081 Jones et al. Jan 2011 A1
20110015636 Katrana et al. Jan 2011 A1
20110015639 Metzger et al. Jan 2011 A1
20110015752 Meridew Jan 2011 A1
20110015753 Meridew Jan 2011 A1
20110016690 Narainasamy et al. Jan 2011 A1
20110022049 Huebner et al. Jan 2011 A1
20110022174 Holdstein et al. Jan 2011 A1
20110029088 Rauscher et al. Feb 2011 A1
20110029091 Bojarski et al. Feb 2011 A1
20110029116 Jordan et al. Feb 2011 A1
20110035012 Linares Feb 2011 A1
20110040303 Iannotti Feb 2011 A1
20110040334 Kaes et al. Feb 2011 A1
20110046735 Metzger et al. Feb 2011 A1
20110054478 Vanasse et al. Mar 2011 A1
20110066193 Lang et al. Mar 2011 A1
20110066245 Lang et al. Mar 2011 A1
20110071528 Carson Mar 2011 A1
20110071529 Carson Mar 2011 A1
20110071530 Carson Mar 2011 A1
20110071532 Carson Mar 2011 A1
20110071533 Metzger et al. Mar 2011 A1
20110071581 Lang et al. Mar 2011 A1
20110071802 Bojarski et al. Mar 2011 A1
20110087332 Bojarski et al. Apr 2011 A1
20110092804 Schoenefeld et al. Apr 2011 A1
20110093086 Witt et al. Apr 2011 A1
20110106093 Romano et al. May 2011 A1
20110106254 Abel et al. May 2011 A1
20110125264 Bagga et al. May 2011 A1
20110125284 Gabbrielli et al. May 2011 A1
20110130795 Ball Jun 2011 A1
20110151027 Clineff et al. Jun 2011 A1
20110151259 Jarman-smith et al. Jun 2011 A1
20110153025 Mcminn Jun 2011 A1
20110160736 Meridew et al. Jun 2011 A1
20110160867 Meridew et al. Jun 2011 A1
20110166578 Stone et al. Jul 2011 A1
20110172672 Dubeau et al. Jul 2011 A1
20110177590 Clyne et al. Jul 2011 A1
20110184419 Meridew et al. Jul 2011 A1
20110184424 Isch et al. Jul 2011 A1
20110184526 White et al. Jul 2011 A1
20110190899 Pierce et al. Aug 2011 A1
20110190901 Weissberg et al. Aug 2011 A1
20110213376 Maxson et al. Sep 2011 A1
20110214279 Park et al. Sep 2011 A1
20110218545 Catanzarite et al. Sep 2011 A1
20110224674 White et al. Sep 2011 A1
20110238071 Fernandez-scoma Sep 2011 A1
20110245835 Dodds et al. Oct 2011 A1
20110251617 Ammann et al. Oct 2011 A1
20110257657 Turner et al. Oct 2011 A1
20110002691 Furrer et al. Nov 2011 A1
20110275032 Tardieu et al. Nov 2011 A1
20110276145 Carignan et al. Nov 2011 A1
20110282473 Pavlovskaia et al. Nov 2011 A1
20110295887 Palmese et al. Dec 2011 A1
20110313424 Bono et al. Dec 2011 A1
20110319745 Frey Dec 2011 A1
20120001071 Frigg Jan 2012 A1
20120004662 Torrie Jan 2012 A1
20120010619 Barsoum Jan 2012 A1
20120010711 Antonyshyn et al. Jan 2012 A1
20120029345 Mahfouz et al. Feb 2012 A1
20120029520 Lang et al. Feb 2012 A1
20120041445 Roose et al. Feb 2012 A1
20120041564 Landon Feb 2012 A1
20120046526 Boettner Feb 2012 A1
20120065640 Metzger et al. Mar 2012 A1
20120071893 Smith Mar 2012 A1
20120078254 Ashby et al. Mar 2012 A1
20120078258 Lo et al. Mar 2012 A1
20120078259 Meridew Mar 2012 A1
20120089595 Jaecksch et al. Apr 2012 A1
20120101586 Carson Apr 2012 A1
20120109137 Iannotti et al. May 2012 A1
20120109138 Meridew et al. May 2012 A1
20120109226 Iannotti et al. May 2012 A1
20120116203 Vancraen et al. May 2012 A1
20120123422 Agnihotri et al. May 2012 A1
20120123423 Fryman May 2012 A1
20120130382 Iannotti et al. May 2012 A1
20120136365 Iannotti et al. May 2012 A1
20120141034 Iannotti et al. Jun 2012 A1
20120143197 Lang et al. Jun 2012 A1
20120143267 Iannotti et al. Jun 2012 A1
20120150242 Mannion Jun 2012 A1
20120158002 Carignan et al. Jun 2012 A1
20120165954 Nimal Jun 2012 A1
20120192401 Pavlovskaia et al. Aug 2012 A1
20120209276 Schuster Aug 2012 A1
20120215225 Philippon et al. Aug 2012 A1
20120215310 Sharp et al. Aug 2012 A1
20120221017 Bonutti Aug 2012 A1
20120226283 Meridew et al. Sep 2012 A1
20120232596 Ribeiro Sep 2012 A1
20120245587 Fang et al. Sep 2012 A1
20120259335 Seifert et al. Oct 2012 A1
20120265208 Smith Oct 2012 A1
20120271131 Kling Oct 2012 A1
20120271314 Stemniski et al. Oct 2012 A1
20120271366 Katrana et al. Oct 2012 A1
20120277751 Catanzarite et al. Nov 2012 A1
20120289965 Gelaude et al. Nov 2012 A1
20120296339 Iannotti et al. Nov 2012 A1
20120303004 Uthgenannt et al. Nov 2012 A1
20120303033 Weiner et al. Nov 2012 A1
20120310364 Li et al. Dec 2012 A1
20120310399 Metzger Dec 2012 A1
20120316564 Serbousek et al. Dec 2012 A1
20120323246 Catanzarite et al. Dec 2012 A1
20120323282 Brlanza et al. Dec 2012 A1
20120323323 Vargas et al. Dec 2012 A1
20130001121 Metzger Jan 2013 A1
20130006250 Metzger et al. Jan 2013 A1
20130018483 Li et al. Jan 2013 A1
20130004631 Ranawat et al. Feb 2013 A1
20130035766 Meridew Feb 2013 A1
20130053854 Schoenefeld et al. Feb 2013 A1
20130056912 O'neill et al. Mar 2013 A1
20130060253 Couture et al. Mar 2013 A1
20130072940 Dawood et al. Mar 2013 A1
20130085500 Meridew et al. Apr 2013 A1
20130085590 Bryan et al. Apr 2013 A1
20130123850 Schoenefeld et al. May 2013 A1
20130131681 Katrana et al. May 2013 A1
20130144392 Hughes Jun 2013 A1
20130197528 Zakaria et al. Aug 2013 A1
20130197529 Metzger Aug 2013 A1
20130197687 Pavlovskaia et al. Aug 2013 A1
20130218163 Frey Aug 2013 A1
20130245631 Bettenga Sep 2013 A1
20130245801 Schroeder Sep 2013 A1
20130261503 Sherman Oct 2013 A1
20130264749 Jones et al. Oct 2013 A1
20130268085 Dong Oct 2013 A1
20130289730 Gabriel et al. Oct 2013 A1
20130317511 Bojarski et al. Nov 2013 A1
20130326878 Boehm et al. Dec 2013 A1
20130338673 Keppler Dec 2013 A1
20140005672 Edwards et al. Jan 2014 A1
20140012266 Bonin, Jr. et al. Jan 2014 A1
20140052270 Witt et al. Feb 2014 A1
20140066937 Wiebe, III et al. Mar 2014 A1
20140081659 Nawana et al. Mar 2014 A1
20140088724 Meridew Mar 2014 A1
20140094816 White et al. Apr 2014 A1
20140100578 Metzger et al. Apr 2014 A1
20140107651 Meridew et al. Apr 2014 A1
20140107654 Kehres et al. Apr 2014 A1
20140107715 Heilman et al. Apr 2014 A1
20140081275 Metzger et al. May 2014 A1
20140127211 Geles et al. May 2014 A1
20140135775 Maxson May 2014 A1
20140163564 Bollinger Jun 2014 A1
20140163565 Bollinger Jun 2014 A1
20140172116 Maxson et al. Jun 2014 A1
20140188119 Catanzarite et al. Jul 2014 A1
20140222157 Al Hares et al. Aug 2014 A1
20140243833 Smith Aug 2014 A1
20140257304 Eash Sep 2014 A1
20140257508 Bojarski et al. Sep 2014 A1
20140276854 Schoenefeld et al. Sep 2014 A1
20140276856 Schoenfeld Sep 2014 A1
20140276870 Eash Sep 2014 A1
20140276873 Meridew et al. Sep 2014 A1
20140303938 Schoenefeld et al. Oct 2014 A1
20140303990 Schoenefeld et al. Oct 2014 A1
20140309644 Metzger et al. Oct 2014 A1
20140324058 Metzger et al. Oct 2014 A1
20140378979 Stone et al. Dec 2014 A1
20150088293 Metzger Mar 2015 A1
20160278793 Meridew et al. Sep 2016 A1
Foreign Referenced Citations (149)
Number Date Country
2447694 Dec 2002 CA
2501041 Apr 2004 CA
2505371 May 2004 CA
2505419 Jun 2004 CA
2506849 Jun 2004 CA
2546958 Jun 2005 CA
2546965 Jun 2005 CA
2588907 Jun 2006 CA
2590534 Jun 2006 CA
1630495 Jun 2005 CN
1728976 Feb 2006 CN
1729483 Feb 2006 CN
1729484 Feb 2006 CN
1913844 Feb 2007 CN
101111197 Jan 2008 CN
102038553 May 2011 CN
102335742 Feb 2012 CN
3447365 Jul 1986 DE
04219939 Dec 1993 DE
4421153 Dec 1995 DE
10341187 Mar 2005 DE
102009028503 Feb 2011 DE
102011082902 Mar 2012 DE
102012205820 Oct 2012 DE
112010003901 Nov 2012 DE
0114505 Aug 1984 EP
0255797 Feb 1988 EP
0326768 Aug 1989 EP
0579868 Jan 1994 EP
0591985 Apr 1994 EP
0645984 Apr 1995 EP
0650706 May 1995 EP
0916324 May 1999 EP
1321107 Jun 2003 EP
1327424 Jul 2003 EP
1437102 Jul 2004 EP
01486900 Dec 2004 EP
1634551 Mar 2006 EP
1832239 Sep 2007 EP
1852072 Nov 2007 EP
2168507 Mar 2010 EP
2502582 Sep 2012 EP
2709568 Mar 2014 EP
2659226 Sep 1991 FR
2721195 Dec 1995 FR
2768916 Apr 1999 FR
2979817 Mar 2013 FR
2094590 Sep 1982 GB
2197790 Jun 1988 GB
2442441 Apr 2008 GB
2447702 Sep 2008 GB
59157715 Sep 1984 JP
60231208 Nov 1985 JP
6233790 Aug 1994 JP
2000245758 Sep 2000 JP
2005218861 Aug 2005 JP
2009514612 Apr 2009 JP
2011505080 Feb 2011 JP
2011527885 Nov 2011 JP
20050072500 Jul 2005 KR
20050084024 Aug 2005 KR
2083179 Jul 1997 RU
2113182 Jun 1998 RU
2125835 Feb 1999 RU
2138223 Sep 1999 RU
2175534 Nov 2001 RU
2187975 Aug 2002 RU
2218242 Dec 2003 RU
231755 May 2005 TW
WO-8807840 Oct 1988 WO
WO-9107139 May 1991 WO
WO-9325157 Dec 1993 WO
WO-9528688 Oct 1995 WO
WO-9952473 Oct 1999 WO
WO-9959106 Nov 1999 WO
WO-0170142 Sep 2001 WO
WO-0184479 Nov 2001 WO
WO-0217821 Mar 2002 WO
WO-2002026145 Apr 2002 WO
WO-0236024 May 2002 WO
WO-02096268 Dec 2002 WO
WO-03051210 Jun 2003 WO
WO-03051211 Jun 2003 WO
WO-2004032806 Apr 2004 WO
WO-2004049981 Jun 2004 WO
WO-2004051301 Jun 2004 WO
WO-2004078069 Sep 2004 WO
WO-2005051233 Jun 2005 WO
WO-2005051239 Jun 2005 WO
WO-2005051240 Jun 2005 WO
WO-2005077039 Aug 2005 WO
WO-06060795 Jun 2006 WO
WO-2006058057 Jun 2006 WO
WO-2006092600 Sep 2006 WO
WO-2006127486 Nov 2006 WO
WO-2006134345 Dec 2006 WO
WO-2006136955 Dec 2006 WO
WO-07041375 Apr 2007 WO
WO-2007053572 May 2007 WO
WO-2007062079 May 2007 WO
WO-2007092841 Aug 2007 WO
WO-2007137327 Dec 2007 WO
WO-2007145937 Dec 2007 WO
WO-2008014618 Feb 2008 WO
WO-2008021494 Feb 2008 WO
WO-2008040961 Apr 2008 WO
WO-2008044055 Apr 2008 WO
WO-2008091358 Jul 2008 WO
WO-2008101090 Aug 2008 WO
WO-2008109751 Sep 2008 WO
WO-2008112996 Sep 2008 WO
WO-2008140748 Nov 2008 WO
WO-2009001083 Dec 2008 WO
WO-2009001109 Dec 2008 WO
WO-2009025783 Feb 2009 WO
WO-2009073781 Jun 2009 WO
WO-2009129063 Oct 2009 WO
WO-2009129067 Oct 2009 WO
WO-2010033431 Mar 2010 WO
WO-2010093902 Aug 2010 WO
WO-2010096553 Aug 2010 WO
WO-2010096557 Aug 2010 WO
WO-2010124164 Oct 2010 WO
WO-2010129870 Nov 2010 WO
WO-2010144705 Dec 2010 WO
WO-2010148103 Dec 2010 WO
WO-2010150223 Dec 2010 WO
WO-2011018458 Feb 2011 WO
WO-2011019797 Feb 2011 WO
WO-2011041398 Apr 2011 WO
WO-2011060536 May 2011 WO
WO-2011080260 Jul 2011 WO
WO-2011106711 Sep 2011 WO
WO-2011109260 Sep 2011 WO
WO-2011110374 Sep 2011 WO
WO-2011117644 Sep 2011 WO
WO-2012006444 Jan 2012 WO
WO-2012033821 Mar 2012 WO
WO-2012058344 May 2012 WO
WO-2012058349 May 2012 WO
WO-2012058353 May 2012 WO
WO-2012058355 May 2012 WO
WO-2012061042 May 2012 WO
WO-2012116206 Aug 2012 WO
WO-2012158917 Nov 2012 WO
WO-2012173929 Dec 2012 WO
WO-2012174008 Dec 2012 WO
WO-2013170872 Nov 2013 WO
WO-2014019712 Feb 2014 WO
Non-Patent Literature Citations (169)
Entry
“3D-Implantatplanung und Stereolithographielmplantatbohrschablonen”, Stomatologie 101.3, (2004), 55-59.
“Amazing Precision. Beautiful Results. The next evolution of MAKOplasty® is here”, MAKO Surgical Corp., (Feb. 2009), 6 pgs.
“U.S. Appl. No. 13/627,626, Non Final Office Action dated Aug. 5, 2015”, 9 pgs.
“U.S. Appl. No. 13/627,626, Notice of Allowance dated Mar. 10, 2016”, 6 pgs.
“U.S. Appl. No. 13/627,626, Response filed Feb. 24, 2015 to Restriction Requirement dated Dec. 24, 2014”, 18 pgs.
“U.S. Appl. No. 13/627,626, Response filed Nov. 3, 2015 to Non Final Office Action dated Aug. 5, 2015”, 17 pgs.
“U.S. Appl. No. 13/627,626, Restriction Requirement dated Dec. 24, 2014”, 10 pgs.
“U.S. Appl. No. 15/179,218, Final Office Action dated Apr. 9, 2019”, 6 pgs.
“U.S. Appl. No. 15/179,218, Non Final Office Action dated Nov. 26, 2018”, 7 pgs.
“U.S. Appl. No. 15/179,218, Notice of Allowance dated Jun. 24, 2019”, 6 pgs.
“U.S. Appl. No. 15/179,218, Preliminary Amendment filed Jul. 27, 2016”, 8 pgs.
“U.S. Appl. No. 15/179,218, Response filed Jun. 10, 2019 to Final Office Action dated Apr. 9, 2019”, 12 pgs.
“U.S. Appl. No. 15/179,218, Response fled Feb. 26, 2019 to Non Final Office Action dated Nov. 26, 2018”, 14 pgs.
“Ascent Total Knee System”, Biomet, Inc., (Oct. 31, 1999), 16 pgs.
“Australian Application Serial No. 2013222609, First Examiner Report dated Feb. 16, 2015”, 5 pgs.
“Comprehensive® Reverse Shoulder System”, Biomet Orthopedics brochure, (2009), 8 pgs.
“Comprehensive® Reverse Shoulder System Surgical Technique”, Biomet Orthopedics, (2009-2012), 48 pgs.
“Comprehensive® Reverse Shoulder System Technical Design Features”, Biomet Orthopedics, (2009), 3 pgs.
“Comprehensive® Shoulder System Surgical Technique”, Biomet Orthopedics brochure, (2007), 1-53.
“Comprehensive® Total Shoulder System”, Biomet Orthopedics brochure, (2011), 4 pgs.
“Customized Patient Instruments, Patient specific instruments for patient specific needs”, DePuy Orthopaedics, Inc., (2008), 14 pgs.
“Customized Patient Instruments, Primary Cruciate Retaining Surgical Technique for use with the Sigma® Knee System Utilizing Specialist® 2 Instrumentation”, DePuy Orthopaedics, Inc., (2008), 1-23.
“Discovery® Elbow System”, Biomet Orthopedics, Inc., (Nov. 30, 2007), 3 pgs.
“Discovery® Elbow System Surgical Technique”, Biomet Orthopedics, Inc., (Dec. 31, 2008), 1-25.
“European Application Serial No. 07809326.7, Examination Notification Art. 94(3) dated Jan. 22, 2015”, 6 pgs.
“European Application Serial No. 07809326.7, Extended European Search Report dated Nov. 15, 2011”, 6 pgs.
“European Application Serial No. 09731923.0, Examination Notification Art. 94(3) dated Feb. 10, 2015”, 7 pgs.
“European Application Serial No. 10705064.3, Examination Notification Art. 94(3) dated Feb. 4, 2015”, 6 pgs.
“European Application Serial No. 12724475.4, Examination Notification Art. 94(3) dated Nov. 24, 2014”, 7 pgs.
“Great Britain Application Serial No. 1116054.6, Search Report dated Dec. 21, 2011”, 4 pgs.
“Hipsextant Instructions of Use”, Surgical Planning Associates, Inc., (2011), 19 pgs.
“International Application Serial No. PCT/EP2010/061630, International Search Report dated Nov. 30, 2010”, 3 pgs.
“International Application Serial No. PCT/US2007/013223, International Preliminary Report on Patentability dated Dec. 24, 2008”, 5 pgs.
“International Application Serial No. PCT/US2007/013223, International Search Report dated Nov. 26, 2007”, 3 pgs.
“International Application Serial No. PCT/US2007/013223, Written Opinion dated Nov. 26, 2007”, 4 pgs.
“International Application Serial No. PCT/US2009/039507, International Preliminary Report on Patentability dated Oct. 28, 2010”, 9 pgs.
“International Application Serial No. PCT/US2009/039507, International Search Report dated Jul. 14, 2009”, 6 pgs.
“International Application Serial No. PCT/US2009/039507, Written Opinion dated Jul. 14, 2009”, 7 pgs.
“International Application Serial No. PCT/US2009/039578, International Preliminary Report on Patentability dated Oct. 28, 2010”, 9 pgs.
“International Application Serial No. PCT/US2009/039578, International Search Report dated Jul. 31, 2009”, 6 pgs.
“International Application Serial No. PCT/US2009/039578, Written Opinion dated Jul. 31, 2009”, 7 pgs.
“International Application Serial No. PCT/US2009/056670, International Preliminary Report on Patentability dated Mar. 31, 2011”, 12 pgs.
“International Application Serial No. PCT/US2009/056670, International Search Report dated Mar. 2, 2010”, 7 pgs.
“International Application Serial No. PCT/US2009/056670, Invitation to Pay Additional Fees and Partial Search Report dated Nov. 26, 2009”.
“International Application Serial No. PCT/US2009/056670, Written Opinion dated Mar. 2, 2010”, 10 pgs.
“International Application Serial No. PCT/US2010/024073, International Preliminary Report on Patentability dated Aug. 25, 2011”, 8 pgs.
“International Application Serial No. PCT/US2010/024073, International Search Report dated Jun. 4, 2010”, 4 pgs.
“International Application Serial No. PCT/US2010/024073, Written Opinion dated Jun. 4, 2010”, 6 pgs.
“International Application Serial No. PCT/US2010/024579, International Preliminary Report on Patentability dated Sep. 1, 2011”, 7 pgs.
“International Application Serial No. PCT/US2010/024579, International Search Report dated Apr. 22, 2010”, 3 pgs.
“International Application Serial No. PCT/US2010/024579, Written Opinion dated Apr. 22, 2010”, 5 pgs.
“International Application Serial No. PCT/US2010/024584, International Preliminary Report on Patentability dated Sep. 1, 2011”, 8 pgs.
“International Application Serial No. PCT/US2010/024584, International Search Report dated Aug. 19, 2010”, 6 pgs.
“International Application Serial No. PCT/US2010/024584, Written Opinion dated Aug. 19, 2010”, 6 pgs.
“International Application Serial No. PCT/US2010/038177, International Preliminary Report on Patentability dated Dec. 22, 2011”, 10 pgs.
“International Application Serial No. PCT/US2010/038177, International Search Report dated Aug. 24, 2010”, 4 pgs.
“International Application Serial No. PCT/US2010/038177, Written Opinion dated Aug. 24, 2010”, 8 pgs.
“International Application Serial No. PCT/US2010/038845, International Preliminary Report on Patentability dated Jan. 5, 2012”, 9 pgs.
“International Application Serial No. PCT/US2010/038845, International Search Report dated Oct. 5, 2010”, 4 pgs.
“International Application Serial No. PCT/US2010/038845, Written Opinion dated Oct. 5, 2010”, 7 pgs.
“International Application Serial No. PCT/US2010/050701, International Preliminary Report on Patentability dated Apr. 12, 2012”, 10 pgs.
“International Application Serial No. PCT/US2010/050701, International Search Report dated Dec. 7, 2010”, 6 pgs.
“International Application Serial No. PCT/US2010/050701, Written Opinion dated Dec. 7, 2010”, 8 pgs.
“International Application Serial No. PCT/US2011/026333, International Preliminary Report on Patentability dated Sep. 7, 2012”, 10 pgs.
“International Application Serial No. PCT/US2011/026333, International Search Report dated Aug. 9, 2011”, 6 pgs.
“International Application Serial No. PCT/US2011/026333, Invitation to Pay Additional Fees dated May 3, 2011”.
“International Application Serial No. PCT/US2011/026333, Written Opinion dated Aug. 9, 2011”, 8 pgs.
“International Application Serial No. PCT/US2011/026412, International Search Report dated May 9, 2011”, 5 pgs.
“International Application Serial No. PCT/US2011/026412, Written Opinion dated May 9, 2011”, 6 pgs.
“International Application Serial No. PCT/US2011/057300, International Search Report dated Mar. 5, 2012”, 7 pgs.
“International Application Serial No. PCT/US2011/057300, Written Opinion dated Mar. 5, 2012”, 9 pgs.
“International Application Serial No. PCT/US2012/026356, International Preliminary Report on Patentability dated Sep. 6, 2013”, 8 pgs.
“International Application Serial No. PCT/US2012/026356, International Search Report dated May 8, 2012”, 5 pgs.
“International Application Serial No. PCT/US2012/026356, Written Opinion dated May 8, 2012”, 6 pgs.
“International Application Serial No. PCT/US2012/038351, International Preliminary Report on Patentability dated Nov. 28, 2013”, 9 pgs.
“International Application Serial No. PCT/US2012/038351, Written Opinion dated Jul. 6, 2012”, 8 pgs.
“International Application Serial No. PCT/US2012/041893, International Search Report dated Oct. 23, 2012”, 5 pgs.
“International Application Serial No. PCT/US2012/042081, International Preliminary Report on Patentability dated Jan. 3, 2014”, 7 pgs.
“International Application Serial No. PCT/US2012/042081, Written Opinion dated Sep. 5, 2012”, 6 pgs.
“International Application Serial No. PCT/US2012/052853, International Preliminary Report on Patentability dated Mar. 13, 2014”, 14 pgs.
“International Application Serial No. PCT/US2012/052853, International Search Report dated Nov. 15, 2012”, 6 pgs.
“International Application Serial No. PCT/US2012/052853, Written Opinion dated Nov. 15, 2012”, 12 pgs.
“International Application Serial No. PCT/US2012/059189, International Preliminary Report on Patentability dated Apr. 24, 2014”, 10 pgs.
“International Application Serial No. PCT/US2012/059189, International Search Report dated Dec. 18, 2012”, 6 pgs.
“International Application Serial No. PCT/US2012/059189, Written Opinion dated Dec. 18, 2012”, 9 pgs.
“International Application Serial No. PCT/US2012/060842, International Preliminary Report on Patentability dated May 8, 2014”, 7 pgs.
“International Application Serial No. PCT/US2012/060842, International Search Report dated Feb. 6, 2013”, 4 pgs.
“International Application Serial No. PCT/US2012/060842, Written Opinion dated Feb. 6, 2013”, 5 pgs.
“International Application Serial No. PCT/US2012/060848, International Preliminary Report on Patentability dated May 8, 2014”, 11 pgs.
“International Application Serial No. PCT/US2012/060848, Invitation to Pay Additional Fees dated Feb. 6, 2013”.
“International Application Serial No. PCT/US2012/060848, Written Opinion dated Apr. 12, 2013”, 9 pgs.
“International Application Serial No. PCT/US2012/060853, International Preliminary Report on Patentability dated May 8, 2014”, 11 pgs.
“International Application Serial No. PCT/US2012/060853, Written Opinion dated Apr. 9, 2013”, 9 pgs.
“International Application Serial No. PCT/US2012/060854, International Preliminary Report on Patentability dated May 8, 2014”, 8 pgs.
“International Application Serial No. PCT/US2012/060854, International Search Report dated Feb. 6, 2013”, 4 pgs.
“International Application Serial No. PCT/US2012/060854, Written Opinion dated Feb. 6, 2013”, 6 pgs.
“International Application Serial No. PCT/US2013/026875, International Preliminary Report on Patentability dated Sep. 4, 2014”, 9 pgs.
“International Application Serial No. PCT/US2013/026875, International Search Report dated Jun. 7, 2013”, 5 pgs.
“International Application Serial No. PCT/US2013/026875, Written Opinion dated Jun. 7, 2013”, 8 pgs.
“International Application Serial No. PCT/US2013/057097, International Preliminary Report on Patentability dated Mar. 12, 2015”, 10 pgs.
“International Application Serial No. PCT/US2013/057097, International Search Report dated Oct. 14, 2013”, 6 pgs.
“International Application Serial No. PCT/US2013/057097, Written Opinion dated Oct. 14, 2013”, 9 pgs.
“International Application Serial No. PCT/US2013/067505, International Search Report dated Apr. 14, 2014”, 5 pgs.
“International Application Serial No. PCT/US2013/067505, Invitation to Pay Additional Fees dated Feb. 6, 2014”, 6 pgs.
“International Application Serial No. PCT/US2013/067505, Written Opinion dated Apr. 14, 2014”, 11 pgs.
“International Application Serial No. PCT/US2013/074288, International Search Report dated May 23, 2014”, 7 pgs.
“International Application Serial No. PCT/US2013/074288, Written Opinion dated May 23, 2014”, 11 pgs.
“International Application Serial No. PCT/US2014/022000, International Search Report dated Jun. 24, 2014”, 3 pgs.
“International Application Serial No. PCT/US2014/022000, Written Opinion dated Jun. 24, 2014”, 5 pgs.
“International Application Serial No. PCT/US2014/023655, International Search Report dated Jul. 10, 2014”, 4 pgs.
“International Application Serial No. PCT/US2014/023655, Written Opinion dated Jul. 10, 2014”, 6 pgs.
“Is Subchondroplasty® Right for Me?”, [Online] retrieved from the internet: <http://www.subchondroplast}′. . . com/about subchondroplast}'./is subchondroplasty right for >, (Jul. 1, 2013), 1 pg.
“Japanese Application Serial No. 2014-511538, Office Action dated Apr. 7, 2015”, (W/ English Translation), 5 pgs.
“Knee tensor combined with laser femoral head locator”, Research Disclosure, No. 507, (Jul. 2006), 903.
“MAX-Ti™ Modular Protrusio Cage”, Surgical Technique brochure. Biomet Orthopedics, Inc., (2003), 10 pgs.
“MAX-Ti™ Modular Protrusio Cage”, Surgical Technique brochure. Biomet Orthopedics, Inc., (2006), 12 pgs.
“Method for constructing an allograft sleeve”, Research Disclosure, No. 476, (Dec. 2003), 1294.
“OSS™ Orthopaedic Salvage System, Femoral/Tibial Augmentation”, Biomet Orthopedics, Inc. (Mar. 31, 2004), 1-8.
“Oxford® Partial Knee”, Biomet, (Feb. 2011), 8 pgs.
“Oxford® Partial Knee Microplasty® Instrumentation Surgical Technique”, Biomet, (May 2011), 1-54.
“PAR 5™ Protrusio Acetabular Reconstruction System”, Biomet Orthopedics, Inc., (2006), 12 pgs.
“Patient Matched PMI Implants, C.A.M.R.A. 3-D Imaging”, Brochure, Biomet, Inc., Form Y-BMI-191/013191, (1991), 6 pgs.
“Regenerex® Tibial Cone Augment, Surgical Technique Addendum to the Vanguard® SSK Revision System”, brochure. Biomet® Orthopedics., (Mar. 31, 2010), 1-8.
“Signature™ Hip Technology Personalized Patient Care brochure”, Biomet® Orthopedics., (2013), 8 pgs.
“Signature™ Personalized Patient Care”, Surgical Technique Acetabular Guide System brochure, Biomet® Orthopedics, (2013), 1-13.
“Signature™ Personalized Patient Care, Surgical Technique Addendum to the Vanguard Knee System”, Biomet® Orthopedics Brochure, (May 15, 2009), 1-8.
“Subchondroplasty”, [Online] retrieved from the internet: <http://www.subchondroplasty.com/>, (Jul. 1, 2013), 1 pg.
“The Oxford® Partial Knee Surgical Technique”, Biomet, (Feb. 2010), 1-38.
“TruMatch™ Personalized knee replacement solutions”, SIGMA® DePuy Orthopaedics, Inc, tri-fold brochure, (2009), 2 pgs.
“Vanguard® PFR Partial Knee Patellofemoral Replacement System”, Surgical Technique, Biomet Orthopaedics,, (Aug. 31, 2010), 1-25.
“What is Subchondroplasty”, [Online]. Retrieved from the Internet: <http://www.subchondroplasty.com/about subchondroplasty/what is subchondroplasty.>, (Jul. 1, 2013), 2 pgs.
“Zimmer® UniSpacer® Knee System”, Zimmer, Inc., (2005), 4 pgs.
Beaule, P E, et al., “The Young Adult With Hip Impingement: Deciding on The Optimal Intervention”, J Bone Joint Surg Am, (2009), 210-221.
Birnbaum, Klaus M. D, “Computer-Assisted Orthopedic Surgery With Individual Templates and Comparison to Conventional Method”, SPINE vol. 26, No. 4, Lippincott Williams & Wilkins, Inc., (2001), 365-370.
Botha, Charl P, “Technical Report: DeVIDE—The Delft Visualisation and Image processing Development Environment”, (May 31, 2006), 1-49.
Cohen, Zohara A, et al., “Knee cartilage topography, thickness, and contact areas from MRI: in-vitro calibration and in-vivo measurements”, Journal of the OsteoArthritis Research Society International. Osteoarthritis and Cartilage, vol. 7; No. 1, (1999), 95-109.
Deakon, “Posterior Cruciate Ligament Reconstruction Technique Using the Modular ACL/PCL Guide Rationale and Surgical Technique”, Arthrotek, a Biomet Company, (2003), 6 pgs.
Eckhoff, Donald G, et al., “Three-Dimensional Mechanics, Kinematics, and Morphology of the Knee Viewed in Virtual Reality”, The Journal of Bone & Joint Surgery, vol. 81, (Dec. 4, 2005), 71-80.
Farr, J, et al., “Anteromedial Tibial Tubercle Osteotomy (Fulkerson Osteotomy)”, Re-print from V. Sanchis-Alfonso (ed), Anterior Knee Pain and patellar Instability, DOI: 10.1007/978-0-85729-507-1_40, © Springer-Verlag London Limited, (2011), 9 pgs.
Farr, J, et al., “Surgical Technique for Anteromedialization of the Tibial Tubercle with the Tracker™ AMZ Guide System”, Sports Medicine and Arthroscopy Review, vol. 2, No. 3, (1994), 12 pgs.
Fortin, Thomas, et al., “Precise Dental Implant Placement in Bone Using Surgical Guides in Conjunction with Medical Imaging Techniques”, Journal of Oral Implantology, Clinical, vol. 26, No. 4, (2000), 300-303.
Friedman, R J, et al., “The Use Of Computerized Tomography In The Measurement Of Glenoid Version”, Journal of Bone & Joint Surgery Am. (JBJS) 1992;74, (Aug. 1992), 1032-1037.
Haaker, R G, et al., “Minimal-invasive navigiert implantierte unikondylare Knieendoprothese”, Orthopade 2006 35: Spinger Medizin Verlag, (Sep. 13, 2006), 1073-1079.
Hafez, M A, et al., “Computer-assisted Total Knee Arthroplasty Using Patient-specific Templating”, Clinical Orthopaedics and Related Research, No. 444 Lippincott Williams & Wilkins, (2006), 184-192.
Hazan, Eric J, “Computer-Assisted Orthopaedic Surgery, A New Paradigm”, Techniques in Orthopaedics® vol. 18, No. 2,, (2003), 221-229.
Hutmacher, Dietmar W, “Scaffolds in tissue engineering bone and cartilage”, Biomaterials, 21(24), (2000), 2529-2543.
Kaus, Michael R, “Automated Segmentation of MR Images of Brain Tumors”, Radiology, vol. 218, No. 2,, (2001), 586-591.
Kelly, Todd C, “Role of Navigation in Total Hip Arthroplasty”, The Journal of Bone & Joint Surgery(2009) vol. 91-A, Supplement 1, (2009), 153-8.
Klein, M, “Robot assisted insertion of craniofacial implants—clinical experience”, CARS 2001, Elsevier Science B.V., (2001), 133-138.
Lombardi, Adolph, et al., “Patient-Specific Approach in Total Knee Arthroplasty”, Knee Orthopedics, ORTHOSuperSite, [Online]. Retrieved from the Internet: <http://www.orthosupersite.com/view.aspx?rid=31419,>, (Sep. 1, 2008), 5 pgs.
Lynch, John A, et al., “Cartilage segmentation of 3D MRI scans of the osteoarthritic knee combining user knowledge and active contours”, Medical Imaging 2000: Image Processing SPIE vol. 3979, (2000), 925-935.
Murphy, S B, et al., “The Hip Sextant: Navigation of Acetabular Component Orientation Using a Mechanical Instrument”, (2009), 1 pg.
Nicholls, Paul M. D, “Trauma Grand Rounds PMI (Patient-Matched Implants)”, Biomet Orthopedics, Inc.,, (Feb. 29, 2000), 1 pg.
Overhoff, H M, et al., “Total Knee Arthroplasty: Coordinate System Definition and Planning based on 3-D Ultrasound Image Volumes”, CARS 2001, Elsevier Science B.V., (2001), 283-288.
Portheine, F, “CT-basierte Planung und DISOS-Schablonennavigation in der Kniegelenkendoprothetik”, Navigation und Robotic in der Gelenk—und Wirbelsaulenchiruqie, Kapitel 32, Springer Verlag, (2003), 262-269.
Portheine, F, et al., “Entwicklung eines klinischen Demonstrators fur die computerunterstutzte Orthopadische Chirurgie mit CT-Bildbasierten Individualschablonen, Bildverarbeitung fur die Medizin”, English version: FIP ID 752773, (1998), 5 pgs.
Portheine, K, “Development of a clinical demonstrator for computer assisted orthopedic surgery with CT-image based individual templates”, Computer Assisted Radiology and Surgery Elsevier Science B.V., English Version of FIP ID 752770, (1997), 944-949.
Radermacher, K, et al., “Computer Integrated Orthopaedic Surgery: Connection of Planning and Execution in Surgical Intervention”, Computer-integrated surgery: technology and clinical applications, (1996), 451-463.
Radermacher, K, et al., “CT Image-Based Planning and Execution of Interventions in Orthopedic Surgery Using Individual Templates, Experimental Results and Aspects of Clinical Applications”, Computer Assisted Orthopedic Surgery (CAOS), Hogrefe & Huber Publishers, (1995), 42-52.
Radermacher, K, et al., “Image Guided Orthopedic Surgery Using Individual Templates”, Springer Berlin/Heidelberg, CVRMed-MRCAS'97, vol. 1205, (1997), 606-615.
Radermacher, K, et al., “Technique for Better Execution of CT Scan Planned Orthopedic Surgery on Bone Structures”, British Library—“The world's knowledge” 2nd Congress of ISCAS Conference, (Jun. 1995), 933-938.
Radermacher, Klaus, et al., “Computer Assisted Orthopaedic Surgery with Image Based Individual Templates”, Clinical Orthopaedics and Related Research No. 354, Lippincott Williams & Wilkins, (Sep. 1998), 28-38.
Sharp, Michael S, “Patient-Specific, Resurfacing Bi-Compartmental Arthuroplasty Futuretech”, Orthopaedic Product News, (Apr. 2008), 12-15.
Sisto, Domenick J, et al., “Custom Patellofemoral Arthroplasty of the Knee Surgical Technique”, Journal of Bone and Joint Surgery, vol. 89-A, (2006), 214-225.
Slamin, John, et al., “Do You Have This Implant in My Size?”, MDT Medical Design Technology, [Online]. Retrieved from the Internet: <http://www.mdtmag.com/scripts/ShowPR.asp?PUBCODE=046&ACCT=0007796& ISSUE . . . >, (Jul. 31, 2008), 3 pgs.
Steinwachs, Matthias Reinhard, “Cartilage Repair—Autologous Chondrocyte Transplantation and Autologous Matrix-induced Chondrogenesis”, European Musculoskeletal Review, (2006), 65-68.
Thoma, W, et al., “Endoprothetischen Versorgung des Kniegelenks auf der Basis eines 3D-computertomographischen Subtraktionversfahrens”, Topic: Computer-aided orthopedic surgery. Orthopedist 2000 29: Sprinqer Verlag W/ Original German Document, (2000), 641-644.
U.S. Appl. No. 13/627,626 U.S. Pat. No. 9,386,993, filed Sep. 26, 2012, Patient-Specific Femoroacetabular Impingement Instruments and Methods.
U.S. Appl. No. 15/179,218, filed Jun. 10, 2016, Patient-Specific Femoroacetabular Impingement Instruments and Methods.
Related Publications (1)
Number Date Country
20200015896 A1 Jan 2020 US
Provisional Applications (1)
Number Date Country
61540857 Sep 2011 US
Continuations (2)
Number Date Country
Parent 15179218 Jun 2016 US
Child 16584134 US
Parent 13627626 Sep 2012 US
Child 15179218 US